Table: quality_incentive_pool_qip_program_data_year_1

py	type	hospital	number	title	report_status	baseline_rate	baseline_rate_annotation_code	target_rate	numerator	numerator_annotation_code	denominator	denominator_annotation_code	achievement_rate	achievement_rate_annotation_code	achievement_value
PY1	DPH	Alameda Health System	Q-PC1	Comprehensive Diabetes Care: A1C Control (<8%) (CDC-H8)	Reported	0	0	0	1476	0	2671	0	55.30%	0	1
PY1	DPH	Alameda Health System	Q-PC2	Comprehensive Diabetes Care: Eye Exam (CDC-E)	Reported	0	0	0	1361	0	2671	0	51.00%	0	1
PY1	DPH	Alameda Health System	Q-PC3	Comprehensive Diabetes Care: Blood Pressure Control (CDC-BP)	Reported	0	0	0	1943	0	2671	0	72.70%	0	1
PY1	DPH	Alameda Health System	Q-PC4	Asthma Medication Ratio (AMR)	Reported	0	0	0	205	0	349	0	58.70%	0	1
PY1	DPH	Alameda Health System	Q-PC5	Medication Reconciliation Post Discharge (MRP)	Reported	0	0	0	1038	0	2002	0	51.90%	0	1
PY1	DPH	Alameda Health System	Q-PC6	7 Day Post-Discharge Follow-Up for High Risk Beneficiaries	Reported	0	0	0	248	0	1026	0	24.20%	0	1
PY1	DPH	Alameda Health System	Q-PC7	Children and Adolescent Access to PCP (CAP)	Reported	N/A	3	N/A	None	None	None	None	None	None	1
PY1	DPH	Alameda Health System	Q-PC7	? 12-24 Months	Reported	0	0	0	366	0	409	0	89.50%	0	1
PY1	DPH	Alameda Health System	Q-PC7	? 25 Months-6 Years	Reported	0	0	0	1952	0	2547	0	76.60%	0	1
PY1	DPH	Alameda Health System	Q-PC7	? 7-11 Years	Reported	0	0	0	1547	0	1980	0	78.10%	0	1
PY1	DPH	Alameda Health System	Q-PC7	? 12-19 Years	Reported	0	0	0	1640	0	2338	0	70.20%	0	1
PY1	DPH	Alameda Health System	Q-PC8	Childhood Immunization Status (CIS) Combination 3	Reported	0	0	0	332	0	401	0	82.80%	0	1
PY1	DPH	Alameda Health System	Q-PC9	Immunization for Adolescents (IMA) Combination 2	Reported	0	0	0	143	0	232	0	61.60%	0	1
PY1	DPH	Alameda Health System	Q-SC1	Atrial Fibrillation and Atrial Flutter: Chronic Anticoagulation Therapy	Reported	0	0	0	117	0	148	0	79.10%	0	1
PY1	DPH	Alameda Health System	Q-SC2	Coronary Artery Disease (CAD): Antiplatelet Therapy	Reported	0	0	0	264	0	271	0	97.40%	0	1
PY1	DPH	Alameda Health System	Q-SC3	Coronary Artery Disease (CAD): Angiotensin-Converting Enzyme (ACE) Inhibitor or Angiotensin-Receptor Blocker (ARB) Therapy - Diabetes or Left Ventricular Systolic Dysfunction (LVEF < 40%)	Reported	0	0	0	316	0	341	0	92.70%	0	1
PY1	DPH	Alameda Health System	Q-SC4	Coronary Artery Disease (CAD): Beta-Blocker Therapy-Prior Myocardial Infarction (MI) or Left Ventricular Systolic Dysfunction (LVEF <40%)	Reported	0	0	0	256	0	275	0	93.10%	0	1
PY1	DPH	Alameda Health System	Q-SC5	Heart Failure (HF): Angiotensin-Converting Enzyme (ACE) Inhibitor or Angiotensin-Receptor Blocker (ARB) Therapy for Left Ventricular Systolic Dysfunction	Reported	0	0	0	140	0	150	0	93.30%	0	1
PY1	DPH	Alameda Health System	Q-SC6	Heart Failure (HF): Beta-Blocker Therapy for Left Ventricular Systolic Dysfunction	Reported	0	0	0	167	0	192	0	87.00%	0	1
PY1	DPH	Alameda Health System	Q-IP1	Surgical Site Infection (SSI) (Reported as SIR)	Reported	0	0	0	None	1	8.837	0	None	1	1
PY1	DPH	Alameda Health System	Q-IP2	Perioperative Care: Selection of Prophylactic Antibiotic - 1st OR 2nd Generation Cephalosporin	Reported	0	0	0	321	0	323	0	99.40%	0	1
PY1	DPH	Alameda Health System	Q-IP3	Perioperative Care: Venous Thromboembolism (VTE) Prophylaxis	Reported	0	0	0	323	0	323	0	100.00%	0	1
PY1	DPH	Alameda Health System	Q-IP4	Prevention of Central Venous Catheter (CVC) - Related Bloodstream Infections	Reported	0	0	0	51	0	1370	0	3.70%	0	1
PY1	DPH	Alameda Health System	Q-IP5	Appropriate Treatment of Methicillin-Sensitive Staphylococcus Aureus (MSSA) Bacteremia	Reported	0	0	0	39	0	47	0	83.00%	0	1
PY1	DPH	Alameda Health System	Q-IP6	Stroke: Discharged on Antithrombotic Therapy (TJC STK-2)	Reported	0	0	0	61	0	98	0	62.20%	0	1
PY1	DPH	Alameda Health System	Q-RU1	Cardiac Stress Imaging Not Meeting Appropriate Use Criteria: Preoperative Evaluation in Low Risk Surgery Patients (QPP)	Reported	0	0	0	0	0	292	0	0.00%	0	1
PY1	DPH	Alameda Health System	Q-RU2	Emergency Department Utilization of CT for Minor Blunt Head Trauma for Patients 18 Years and Older	Not Reported	None	None	None	None	None	None	None	None	None	None
PY1	DPH	Alameda Health System	Q-RU3	Emergency Department Utilization of CT for Minor Blunt Head Trauma for Patients Aged 2 to 17 years old	Not Reported	None	None	None	None	None	None	None	None	None	None
PY1	DPH	Alameda Health System	Q-RU4	Unplanned Reoperation within the 30 Day Postoperative Period (QPP)	Not Reported	None	None	None	None	None	None	None	None	None	None
PY1	DPH	Alameda Health System	Q-RU5	Concurrent Use of Opioids and Benzodiazepines	Reported	N/A	3	N/A	N/A	3	N/A	3	6.10%	0	1
PY1	DPH	Alameda Health System	Q-RU5	? RATE #1	Reported	0	0	0	42	0	689	0	0.00%	0	1
PY1	DPH	Alameda Health System	Q-RU5	? RATE #2	Reported	0	0	0	67	0	985	0	0.00%	0	1
PY1	DPH	Arrowhead Regional Medical Center	Q-PC1	Comprehensive Diabetes Care: A1C Control (<8%) (CDC-H8)	Reported	0	0	0	840	0	1547	0	54.30%	0	1
PY1	DPH	Arrowhead Regional Medical Center	Q-PC2	Comprehensive Diabetes Care: Eye Exam (CDC-E)	Reported	0	0	0	538	0	1547	0	34.80%	0	1
PY1	DPH	Arrowhead Regional Medical Center	Q-PC3	Comprehensive Diabetes Care: Blood Pressure Control (CDC-BP)	Reported	0	0	0	571	0	1547	0	36.90%	0	1
PY1	DPH	Arrowhead Regional Medical Center	Q-PC4	Asthma Medication Ratio (AMR)	Reported	0	0	0	0	0	0	0	0.00%	0	1
PY1	DPH	Arrowhead Regional Medical Center	Q-PC5	Medication Reconciliation Post Discharge (MRP)	Reported	0	0	0	634	0	927	0	68.40%	0	1
PY1	DPH	Arrowhead Regional Medical Center	Q-PC6	7 Day Post-Discharge Follow-Up for High Risk Beneficiaries	Reported	0	0	0	242	0	459	0	52.70%	0	1
PY1	DPH	Arrowhead Regional Medical Center	Q-PC7	Children and Adolescent Access to PCP (CAP)	Reported	N/A	3	N/A	None	None	None	None	None	None	1
PY1	DPH	Arrowhead Regional Medical Center	Q-PC7	? 12-24 Months	Reported	0	0	0	0	0	None	1	None	1	1
PY1	DPH	Arrowhead Regional Medical Center	Q-PC7	? 25 Months-6 Years	Reported	0	0	0	568	0	766	0	74.20%	0	1
PY1	DPH	Arrowhead Regional Medical Center	Q-PC7	? 7-11 Years	Reported	0	0	0	482	0	629	0	76.60%	0	1
PY1	DPH	Arrowhead Regional Medical Center	Q-PC7	? 12-19 Years	Reported	0	0	0	650	0	905	0	71.80%	0	1
PY1	DPH	Arrowhead Regional Medical Center	Q-PC8	Childhood Immunization Status (CIS) Combination 3	Reported	0	0	0	81	0	169	0	47.90%	0	1
PY1	DPH	Arrowhead Regional Medical Center	Q-PC9	Immunization for Adolescents (IMA) Combination 2	Reported	0	0	0	72	0	124	0	58.10%	0	1
PY1	DPH	Arrowhead Regional Medical Center	Q-SC1	Atrial Fibrillation and Atrial Flutter: Chronic Anticoagulation Therapy	Reported	0	0	0	24	0	64	0	37.50%	0	1
PY1	DPH	Arrowhead Regional Medical Center	Q-SC2	Coronary Artery Disease (CAD): Antiplatelet Therapy	Reported	0	0	0	61	0	209	0	29.20%	0	1
PY1	DPH	Arrowhead Regional Medical Center	Q-SC3	Coronary Artery Disease (CAD): Angiotensin-Converting Enzyme (ACE) Inhibitor or Angiotensin-Receptor Blocker (ARB) Therapy - Diabetes or Left Ventricular Systolic Dysfunction (LVEF < 40%)	Reported	0	0	0	52	0	209	0	24.90%	0	1
PY1	DPH	Arrowhead Regional Medical Center	Q-SC4	Coronary Artery Disease (CAD): Beta-Blocker Therapy-Prior Myocardial Infarction (MI) or Left Ventricular Systolic Dysfunction (LVEF <40%)	Reported	0	0	0	51	0	209	0	24.40%	0	1
PY1	DPH	Arrowhead Regional Medical Center	Q-SC5	Heart Failure (HF): Angiotensin-Converting Enzyme (ACE) Inhibitor or Angiotensin-Receptor Blocker (ARB) Therapy for Left Ventricular Systolic Dysfunction	Reported	0	0	0	77	0	201	0	38.30%	0	1
PY1	DPH	Arrowhead Regional Medical Center	Q-SC6	Heart Failure (HF): Beta-Blocker Therapy for Left Ventricular Systolic Dysfunction	Reported	0	0	0	82	0	201	0	40.80%	0	1
PY1	DPH	Arrowhead Regional Medical Center	Q-IP1	Surgical Site Infection (SSI) (Reported as SIR)	Reported	0	0	0	None	1	11.81	0	None	1	1
PY1	DPH	Arrowhead Regional Medical Center	Q-IP2	Perioperative Care: Selection of Prophylactic Antibiotic - 1st OR 2nd Generation Cephalosporin	Reported	0	0	0	0	0	54	0	0.00%	0	1
PY1	DPH	Arrowhead Regional Medical Center	Q-IP3	Perioperative Care: Venous Thromboembolism (VTE) Prophylaxis	Reported	0	0	0	None	1	53	0	None	1	1
PY1	DPH	Arrowhead Regional Medical Center	Q-IP4	Prevention of Central Venous Catheter (CVC) - Related Bloodstream Infections	Reported	0	0	0	12	0	30	0	40.00%	0	1
PY1	DPH	Arrowhead Regional Medical Center	Q-IP5	Appropriate Treatment of Methicillin-Sensitive Staphylococcus Aureus (MSSA) Bacteremia	Reported	0	0	0	0	0	None	1	None	1	1
PY1	DPH	Arrowhead Regional Medical Center	Q-IP6	Stroke: Discharged on Antithrombotic Therapy (TJC STK-2)	Reported	0	0	0	27	0	None	4	None	4	1
PY1	DPH	Arrowhead Regional Medical Center	Q-RU1	Cardiac Stress Imaging Not Meeting Appropriate Use Criteria: Preoperative Evaluation in Low Risk Surgery Patients (QPP)	Not Reported	None	None	None	None	None	None	None	None	None	None
PY1	DPH	Arrowhead Regional Medical Center	Q-RU2	Emergency Department Utilization of CT for Minor Blunt Head Trauma for Patients 18 Years and Older	Not Reported	None	None	None	None	None	None	None	None	None	None
PY1	DPH	Arrowhead Regional Medical Center	Q-RU3	Emergency Department Utilization of CT for Minor Blunt Head Trauma for Patients Aged 2 to 17 years old	Not Reported	None	None	None	None	None	None	None	None	None	None
PY1	DPH	Arrowhead Regional Medical Center	Q-RU4	Unplanned Reoperation within the 30 Day Postoperative Period (QPP)	Reported	0	0	0	None	1	385	0	None	1	1
PY1	DPH	Arrowhead Regional Medical Center	Q-RU5	Concurrent Use of Opioids and Benzodiazepines	Reported	N/A	3	N/A	N/A	3	N/A	3	N/A	3	1
PY1	DPH	Arrowhead Regional Medical Center	Q-RU5	? RATE #1	Reported	0	0	0	11	0	45	0	24.40%	0	1
PY1	DPH	Arrowhead Regional Medical Center	Q-RU5	? RATE #2	Reported	0	0	0	15	0	57	0	26.30%	0	1
PY1	DPH	Contra Costa Regional Medical Center	Q-PC1	Comprehensive Diabetes Care: A1C Control (<8%) (CDC-H8)	Reported	0	0	0	2435	0	4221	0	57.70%	0	1
PY1	DPH	Contra Costa Regional Medical Center	Q-PC2	Comprehensive Diabetes Care: Eye Exam (CDC-E)	Reported	0	0	0	2350	0	4221	0	55.70%	0	1
PY1	DPH	Contra Costa Regional Medical Center	Q-PC3	Comprehensive Diabetes Care: Blood Pressure Control (CDC-BP)	Reported	0	0	0	3196	0	4221	0	75.70%	0	1
PY1	DPH	Contra Costa Regional Medical Center	Q-PC4	Asthma Medication Ratio (AMR)	Reported	0	0	0	534	0	1007	0	53.00%	0	1
PY1	DPH	Contra Costa Regional Medical Center	Q-PC5	Medication Reconciliation Post Discharge (MRP)	Reported	0	0	0	2303	0	2316	0	99.40%	0	1
PY1	DPH	Contra Costa Regional Medical Center	Q-PC6	7 Day Post-Discharge Follow-Up for High Risk Beneficiaries	Reported	0	0	0	127	0	282	0	45.00%	0	1
PY1	DPH	Contra Costa Regional Medical Center	Q-PC7	Children and Adolescent Access to PCP (CAP)	Reported	N/A	3	N/A	None	None	None	None	None	None	1
PY1	DPH	Contra Costa Regional Medical Center	Q-PC7	? 12-24 Months	Reported	0	0	0	1140	0	1220	0	93.40%	0	1
PY1	DPH	Contra Costa Regional Medical Center	Q-PC7	? 25 Months-6 Years	Reported	0	0	0	5218	0	6274	0	83.20%	0	1
PY1	DPH	Contra Costa Regional Medical Center	Q-PC7	? 7-11 Years	Reported	0	0	0	4491	0	5258	0	85.40%	0	1
PY1	DPH	Contra Costa Regional Medical Center	Q-PC7	? 12-19 Years	Reported	0	0	0	5362	0	6435	0	83.30%	0	1
PY1	DPH	Contra Costa Regional Medical Center	Q-PC8	Childhood Immunization Status (CIS) Combination 3	Reported	0	0	0	958	0	1163	0	82.40%	0	1
PY1	DPH	Contra Costa Regional Medical Center	Q-PC9	Immunization for Adolescents (IMA) Combination 2	Reported	0	0	0	362	0	747	0	48.50%	0	1
PY1	DPH	Contra Costa Regional Medical Center	Q-SC1	Atrial Fibrillation and Atrial Flutter: Chronic Anticoagulation Therapy	Reported	0	0	0	341	0	440	0	77.50%	0	1
PY1	DPH	Contra Costa Regional Medical Center	Q-SC2	Coronary Artery Disease (CAD): Antiplatelet Therapy	Reported	0	0	0	1550	0	1700	0	91.20%	0	1
PY1	DPH	Contra Costa Regional Medical Center	Q-SC3	Coronary Artery Disease (CAD): Angiotensin-Converting Enzyme (ACE) Inhibitor or Angiotensin-Receptor Blocker (ARB) Therapy - Diabetes or Left Ventricular Systolic Dysfunction (LVEF < 40%)	Reported	0	0	0	694	0	911	0	76.20%	0	1
PY1	DPH	Contra Costa Regional Medical Center	Q-SC4	Coronary Artery Disease (CAD): Beta-Blocker Therapy-Prior Myocardial Infarction (MI) or Left Ventricular Systolic Dysfunction (LVEF <40%)	Reported	0	0	0	295	0	335	0	88.10%	0	1
PY1	DPH	Contra Costa Regional Medical Center	Q-SC5	Heart Failure (HF): Angiotensin-Converting Enzyme (ACE) Inhibitor or Angiotensin-Receptor Blocker (ARB) Therapy for Left Ventricular Systolic Dysfunction	Reported	0	0	0	325	0	400	0	81.30%	0	1
PY1	DPH	Contra Costa Regional Medical Center	Q-SC6	Heart Failure (HF): Beta-Blocker Therapy for Left Ventricular Systolic Dysfunction	Reported	0	0	0	398	0	421	0	94.50%	0	1
PY1	DPH	Contra Costa Regional Medical Center	Q-IP1	Surgical Site Infection (SSI) (Reported as SIR)	Reported	0	0	0	None	1	4.578	0	None	1	1
PY1	DPH	Contra Costa Regional Medical Center	Q-IP2	Perioperative Care: Selection of Prophylactic Antibiotic - 1st OR 2nd Generation Cephalosporin	Reported	0	0	0	635	0	658	0	96.50%	0	1
PY1	DPH	Contra Costa Regional Medical Center	Q-IP3	Perioperative Care: Venous Thromboembolism (VTE) Prophylaxis	Reported	0	0	0	739	0	753	0	98.10%	0	1
PY1	DPH	Contra Costa Regional Medical Center	Q-IP4	Prevention of Central Venous Catheter (CVC) - Related Bloodstream Infections	Reported	0	0	0	None	1	195	0	None	1	1
PY1	DPH	Contra Costa Regional Medical Center	Q-IP5	Appropriate Treatment of Methicillin-Sensitive Staphylococcus Aureus (MSSA) Bacteremia	Not Reported	None	None	None	None	None	None	None	None	None	None
PY1	DPH	Contra Costa Regional Medical Center	Q-IP6	Stroke: Discharged on Antithrombotic Therapy (TJC STK-2)	Not Reported	None	None	None	None	None	None	None	None	None	None
PY1	DPH	Contra Costa Regional Medical Center	Q-RU1	Cardiac Stress Imaging Not Meeting Appropriate Use Criteria: Preoperative Evaluation in Low Risk Surgery Patients (QPP)	Reported	0	0	0	None	1	954	0	None	1	1
PY1	DPH	Contra Costa Regional Medical Center	Q-RU2	Emergency Department Utilization of CT for Minor Blunt Head Trauma for Patients 18 Years and Older	Not Reported	None	None	None	None	None	None	None	None	None	None
PY1	DPH	Contra Costa Regional Medical Center	Q-RU3	Emergency Department Utilization of CT for Minor Blunt Head Trauma for Patients Aged 2 to 17 years old	Not Reported	None	None	None	None	None	None	None	None	None	None
PY1	DPH	Contra Costa Regional Medical Center	Q-RU4	Unplanned Reoperation within the 30 Day Postoperative Period (QPP)	Not Reported	None	None	None	None	None	None	None	None	None	None
PY1	DPH	Contra Costa Regional Medical Center	Q-RU5	Concurrent Use of Opioids and Benzodiazepines	Reported	N/A	3	N/A	N/A	3	N/A	3	N/A	3	1
PY1	DPH	Contra Costa Regional Medical Center	Q-RU5	? RATE #1	Reported	0	0	0	358	0	4950	0	7.20%	0	1
PY1	DPH	Contra Costa Regional Medical Center	Q-RU5	? RATE #2	Reported	0	0	0	474	0	4950	0	9.60%	0	1
PY1	DPH	Kern Medical Center	Q-PC1	Comprehensive Diabetes Care: A1C Control (<8%) (CDC-H8)	Reported	0	0	0	842	0	1532	0	55.00%	0	1
PY1	DPH	Kern Medical Center	Q-PC2	Comprehensive Diabetes Care: Eye Exam (CDC-E)	Reported	0	0	0	659	0	1532	0	43.00%	0	1
PY1	DPH	Kern Medical Center	Q-PC3	Comprehensive Diabetes Care: Blood Pressure Control (CDC-BP)	Reported	0	0	0	1068	0	1532	0	69.70%	0	1
PY1	DPH	Kern Medical Center	Q-PC4	Asthma Medication Ratio (AMR)	Reported	0	0	0	None	1	118	0	None	1	1
PY1	DPH	Kern Medical Center	Q-PC5	Medication Reconciliation Post Discharge (MRP)	Reported	0	0	0	460	0	678	0	67.90%	0	1
PY1	DPH	Kern Medical Center	Q-PC6	7 Day Post-Discharge Follow-Up for High Risk Beneficiaries	Reported	0	0	0	24	0	93	0	25.80%	0	1
PY1	DPH	Kern Medical Center	Q-PC7	Children and Adolescent Access to PCP (CAP)	Reported	N/A	3	N/A	None	None	None	None	None	None	1
PY1	DPH	Kern Medical Center	Q-PC7	? 12-24 Months	Reported	0	0	0	501	0	687	0	72.90%	0	1
PY1	DPH	Kern Medical Center	Q-PC7	? 25 Months-6 Years	Reported	0	0	0	1840	0	3032	0	60.70%	0	1
PY1	DPH	Kern Medical Center	Q-PC7	? 7-11 Years	Reported	0	0	0	1916	0	3494	0	54.80%	0	1
PY1	DPH	Kern Medical Center	Q-PC7	? 12-19 Years	Reported	0	0	0	2378	0	4555	0	52.20%	0	1
PY1	DPH	Kern Medical Center	Q-PC8	Childhood Immunization Status (CIS) Combination 3	Reported	0	0	0	100	0	408	0	24.50%	0	1
PY1	DPH	Kern Medical Center	Q-PC9	Immunization for Adolescents (IMA) Combination 2	Reported	0	0	0	47	0	151	0	31.10%	0	1
PY1	DPH	Kern Medical Center	Q-SC1	Atrial Fibrillation and Atrial Flutter: Chronic Anticoagulation Therapy	Reported	0	0	0	99	0	110	0	90.00%	0	1
PY1	DPH	Kern Medical Center	Q-SC2	Coronary Artery Disease (CAD): Antiplatelet Therapy	Reported	0	0	0	472	0	513	0	92.00%	0	1
PY1	DPH	Kern Medical Center	Q-SC3	Coronary Artery Disease (CAD): Angiotensin-Converting Enzyme (ACE) Inhibitor or Angiotensin-Receptor Blocker (ARB) Therapy - Diabetes or Left Ventricular Systolic Dysfunction (LVEF < 40%)	Reported	0	0	0	354	0	399	0	88.70%	0	1
PY1	DPH	Kern Medical Center	Q-SC4	Coronary Artery Disease (CAD): Beta-Blocker Therapy-Prior Myocardial Infarction (MI) or Left Ventricular Systolic Dysfunction (LVEF <40%)	Reported	0	0	0	140	0	156	0	89.70%	0	1
PY1	DPH	Kern Medical Center	Q-SC5	Heart Failure (HF): Angiotensin-Converting Enzyme (ACE) Inhibitor or Angiotensin-Receptor Blocker (ARB) Therapy for Left Ventricular Systolic Dysfunction	Reported	0	0	0	104	0	109	0	95.40%	0	1
PY1	DPH	Kern Medical Center	Q-SC6	Heart Failure (HF): Beta-Blocker Therapy for Left Ventricular Systolic Dysfunction	Reported	0	0	0	97	0	101	0	96.00%	0	1
PY1	DPH	Kern Medical Center	Q-IP1	Surgical Site Infection (SSI) (Reported as SIR)	Reported	0	0	0	15	0	8.41	0	1.7836	0	1
PY1	DPH	Kern Medical Center	Q-IP2	Perioperative Care: Selection of Prophylactic Antibiotic - 1st OR 2nd Generation Cephalosporin	Reported	0	0	0	1032	0	1032	0	100.00%	0	1
PY1	DPH	Kern Medical Center	Q-IP3	Perioperative Care: Venous Thromboembolism (VTE) Prophylaxis	Reported	0	0	0	958	0	958	0	100.00%	0	1
PY1	DPH	Kern Medical Center	Q-IP4	Prevention of Central Venous Catheter (CVC) - Related Bloodstream Infections	Reported	0	0	0	457	0	475	0	96.20%	0	1
PY1	DPH	Kern Medical Center	Q-IP5	Appropriate Treatment of Methicillin-Sensitive Staphylococcus Aureus (MSSA) Bacteremia	Not Reported	None	None	None	None	None	None	None	None	None	None
PY1	DPH	Kern Medical Center	Q-IP6	Stroke: Discharged on Antithrombotic Therapy (TJC STK-2)	Reported	0	0	0	31	0	32	0	96.90%	0	1
PY1	DPH	Kern Medical Center	Q-RU1	Cardiac Stress Imaging Not Meeting Appropriate Use Criteria: Preoperative Evaluation in Low Risk Surgery Patients (QPP)	Reported	0	0	0	0	0	0	0	0.00%	0	1
PY1	DPH	Kern Medical Center	Q-RU2	Emergency Department Utilization of CT for Minor Blunt Head Trauma for Patients 18 Years and Older	Reported	0	0	0	0	0	0	0	100.00%	0	1
PY1	DPH	Kern Medical Center	Q-RU3	Emergency Department Utilization of CT for Minor Blunt Head Trauma for Patients Aged 2 to 17 years old	Not Reported	None	None	None	None	None	None	None	None	None	None
PY1	DPH	Kern Medical Center	Q-RU4	Unplanned Reoperation within the 30 Day Postoperative Period (QPP)	Reported	0	0	0	11	0	1029	0	1.10%	0	1
PY1	DPH	Kern Medical Center	Q-RU5	Concurrent Use of Opioids and Benzodiazepines	Reported	N/A	3	N/A	N/A	3	N/A	3	N/A	3	1
PY1	DPH	Kern Medical Center	Q-RU5	? RATE #1	Reported	0	0	0	59	0	482	0	12.20%	0	1
PY1	DPH	Kern Medical Center	Q-RU5	? RATE #2	Reported	0	0	0	56	0	503	0	11.10%	0	1
PY1	DPH	Los Angeles County Health System	Q-PC1	Comprehensive Diabetes Care: A1C Control (<8%) (CDC-H8)	Reported	0	0	0	8169	0	15547	0	52.50%	0	1
PY1	DPH	Los Angeles County Health System	Q-PC2	Comprehensive Diabetes Care: Eye Exam (CDC-E)	Reported	0	0	0	271	0	377	0	71.90%	0	1
PY1	DPH	Los Angeles County Health System	Q-PC3	Comprehensive Diabetes Care: Blood Pressure Control (CDC-BP)	Reported	0	0	0	10278	0	15547	0	66.10%	0	1
PY1	DPH	Los Angeles County Health System	Q-PC4	Asthma Medication Ratio (AMR)	Reported	0	0	0	450	0	945	0	47.60%	0	1
PY1	DPH	Los Angeles County Health System	Q-PC5	Medication Reconciliation Post Discharge (MRP)	Reported	0	0	0	3941	0	8633	0	45.70%	0	1
PY1	DPH	Los Angeles County Health System	Q-PC6	7 Day Post-Discharge Follow-Up for High Risk Beneficiaries	Not Reported	None	None	None	None	None	None	None	None	None	None
PY1	DPH	Los Angeles County Health System	Q-PC7	Children and Adolescent Access to PCP (CAP)	Reported	N/A	3	N/A	None	None	None	None	None	None	1
PY1	DPH	Los Angeles County Health System	Q-PC7	? 12-24 Months	Reported	0	0	0	1279	0	1490	0	85.80%	0	1
PY1	DPH	Los Angeles County Health System	Q-PC7	? 25 Months-6 Years	Reported	0	0	0	5977	0	8822	0	67.80%	0	1
PY1	DPH	Los Angeles County Health System	Q-PC7	? 7-11 Years	Reported	0	0	0	5108	0	7441	0	68.70%	0	1
PY1	DPH	Los Angeles County Health System	Q-PC7	? 12-19 Years	Reported	0	0	0	7373	0	11345	0	65.00%	0	1
PY1	DPH	Los Angeles County Health System	Q-PC8	Childhood Immunization Status (CIS) Combination 3	Reported	0	0	0	279	0	323	0	86.40%	0	1
PY1	DPH	Los Angeles County Health System	Q-PC9	Immunization for Adolescents (IMA) Combination 2	Not Reported	None	None	None	None	None	None	None	None	None	None
PY1	DPH	Los Angeles County Health System	Q-SC1	Atrial Fibrillation and Atrial Flutter: Chronic Anticoagulation Therapy	Reported	0	0	0	678	0	860	0	78.80%	0	1
PY1	DPH	Los Angeles County Health System	Q-SC2	Coronary Artery Disease (CAD): Antiplatelet Therapy	Reported	0	0	0	2991	0	3209	0	93.20%	0	1
PY1	DPH	Los Angeles County Health System	Q-SC3	Coronary Artery Disease (CAD): Angiotensin-Converting Enzyme (ACE) Inhibitor or Angiotensin-Receptor Blocker (ARB) Therapy - Diabetes or Left Ventricular Systolic Dysfunction (LVEF < 40%)	Reported	0	0	0	1560	0	1808	0	86.30%	0	1
PY1	DPH	Los Angeles County Health System	Q-SC4	Coronary Artery Disease (CAD): Beta-Blocker Therapy-Prior Myocardial Infarction (MI) or Left Ventricular Systolic Dysfunction (LVEF <40%)	Reported	0	0	0	1037	0	1216	0	85.30%	0	1
PY1	DPH	Los Angeles County Health System	Q-SC5	Heart Failure (HF): Angiotensin-Converting Enzyme (ACE) Inhibitor or Angiotensin-Receptor Blocker (ARB) Therapy for Left Ventricular Systolic Dysfunction	Reported	0	0	0	475	0	603	0	78.80%	0	1
PY1	DPH	Los Angeles County Health System	Q-SC6	Heart Failure (HF): Beta-Blocker Therapy for Left Ventricular Systolic Dysfunction	Reported	0	0	0	546	0	609	0	89.70%	0	1
PY1	DPH	Los Angeles County Health System	Q-IP1	Surgical Site Infection (SSI) (Reported as SIR)	Reported	0	0	0	11	0	22.472	0	0.4895	0	1
PY1	DPH	Los Angeles County Health System	Q-IP2	Perioperative Care: Selection of Prophylactic Antibiotic - 1st OR 2nd Generation Cephalosporin	Reported	0	0	0	340	0	370	0	91.90%	0	1
PY1	DPH	Los Angeles County Health System	Q-IP3	Perioperative Care: Venous Thromboembolism (VTE) Prophylaxis	Reported	0	0	0	299	0	370	0	80.80%	0	1
PY1	DPH	Los Angeles County Health System	Q-IP4	Prevention of Central Venous Catheter (CVC) - Related Bloodstream Infections	Reported	0	0	0	214	0	370	0	57.80%	0	1
PY1	DPH	Los Angeles County Health System	Q-IP5	Appropriate Treatment of Methicillin-Sensitive Staphylococcus Aureus (MSSA) Bacteremia	Reported	0	0	0	101	0	103	0	98.10%	0	1
PY1	DPH	Los Angeles County Health System	Q-IP6	Stroke: Discharged on Antithrombotic Therapy (TJC STK-2)	Reported	0	0	0	204	0	205	0	99.50%	0	1
PY1	DPH	Los Angeles County Health System	Q-RU1	Cardiac Stress Imaging Not Meeting Appropriate Use Criteria: Preoperative Evaluation in Low Risk Surgery Patients (QPP)	Reported	0	0	0	None	1	377	0	None	1	1
PY1	DPH	Los Angeles County Health System	Q-RU2	Emergency Department Utilization of CT for Minor Blunt Head Trauma for Patients 18 Years and Older	Not Reported	None	None	None	None	None	None	None	None	None	None
PY1	DPH	Los Angeles County Health System	Q-RU3	Emergency Department Utilization of CT for Minor Blunt Head Trauma for Patients Aged 2 to 17 years old	Not Reported	None	None	None	None	None	None	None	None	None	None
PY1	DPH	Los Angeles County Health System	Q-RU4	Unplanned Reoperation within the 30 Day Postoperative Period (QPP)	Not Reported	None	None	None	None	None	None	None	None	None	None
PY1	DPH	Los Angeles County Health System	Q-RU5	Concurrent Use of Opioids and Benzodiazepines	Not Reported	None	None	None	None	None	None	None	None	None	None
PY1	DPH	Natividad Medical Center	Q-PC1	Comprehensive Diabetes Care: A1C Control (<8%) (CDC-H8)	Reported	0	0	0	647	0	1259	0	51.40%	0	1
PY1	DPH	Natividad Medical Center	Q-PC2	Comprehensive Diabetes Care: Eye Exam (CDC-E)	Reported	0	0	0	784	0	1259	0	62.30%	0	1
PY1	DPH	Natividad Medical Center	Q-PC3	Comprehensive Diabetes Care: Blood Pressure Control (CDC-BP)	Reported	0	0	0	926	0	1259	0	73.60%	0	1
PY1	DPH	Natividad Medical Center	Q-PC4	Asthma Medication Ratio (AMR)	Reported	0	0	0	264	0	406	0	65.00%	0	1
PY1	DPH	Natividad Medical Center	Q-PC5	Medication Reconciliation Post Discharge (MRP)	Reported	0	0	0	419	0	729	0	57.50%	0	1
PY1	DPH	Natividad Medical Center	Q-PC6	7 Day Post-Discharge Follow-Up for High Risk Beneficiaries	Reported	0	0	0	22	0	45	0	48.90%	0	1
PY1	DPH	Natividad Medical Center	Q-PC7	Children and Adolescent Access to PCP (CAP)	Reported	N/A	3	N/A	None	None	None	None	None	None	1
PY1	DPH	Natividad Medical Center	Q-PC7	? 12-24 Months	Reported	0	0	0	1421	0	1497	0	94.90%	0	1
PY1	DPH	Natividad Medical Center	Q-PC7	? 25 Months-6 Years	Reported	0	0	0	6462	0	7113	0	90.90%	0	1
PY1	DPH	Natividad Medical Center	Q-PC7	? 7-11 Years	Reported	0	0	0	6577	0	7365	0	89.30%	0	1
PY1	DPH	Natividad Medical Center	Q-PC7	? 12-19 Years	Reported	0	0	0	6787	0	8060	0	84.20%	0	1
PY1	DPH	Natividad Medical Center	Q-PC8	Childhood Immunization Status (CIS) Combination 3	Reported	0	0	0	869	0	989	0	87.90%	0	1
PY1	DPH	Natividad Medical Center	Q-PC9	Immunization for Adolescents (IMA) Combination 2	Reported	0	0	0	561	0	770	0	72.90%	0	1
PY1	DPH	Natividad Medical Center	Q-SC1	Atrial Fibrillation and Atrial Flutter: Chronic Anticoagulation Therapy	Reported	0	0	0	109	0	128	0	85.20%	0	1
PY1	DPH	Natividad Medical Center	Q-SC2	Coronary Artery Disease (CAD): Antiplatelet Therapy	Reported	0	0	0	238	0	297	0	80.10%	0	1
PY1	DPH	Natividad Medical Center	Q-SC3	Coronary Artery Disease (CAD): Angiotensin-Converting Enzyme (ACE) Inhibitor or Angiotensin-Receptor Blocker (ARB) Therapy - Diabetes or Left Ventricular Systolic Dysfunction (LVEF < 40%)	Reported	0	0	0	133	0	161	0	82.60%	0	1
PY1	DPH	Natividad Medical Center	Q-SC4	Coronary Artery Disease (CAD): Beta-Blocker Therapy-Prior Myocardial Infarction (MI) or Left Ventricular Systolic Dysfunction (LVEF <40%)	Reported	0	0	0	65	0	79	0	82.30%	0	1
PY1	DPH	Natividad Medical Center	Q-SC5	Heart Failure (HF): Angiotensin-Converting Enzyme (ACE) Inhibitor or Angiotensin-Receptor Blocker (ARB) Therapy for Left Ventricular Systolic Dysfunction	Reported	0	0	0	28	0	35	0	80.00%	0	1
PY1	DPH	Natividad Medical Center	Q-SC6	Heart Failure (HF): Beta-Blocker Therapy for Left Ventricular Systolic Dysfunction	Reported	0	0	0	24	0	35	0	68.60%	0	1
PY1	DPH	Natividad Medical Center	Q-IP1	Surgical Site Infection (SSI) (Reported as SIR)	Reported	0	0	0	None	1	6.737	0	None	1	1
PY1	DPH	Natividad Medical Center	Q-IP2	Perioperative Care: Selection of Prophylactic Antibiotic - 1st OR 2nd Generation Cephalosporin	Reported	0	0	0	338	0	794	0	42.60%	0	1
PY1	DPH	Natividad Medical Center	Q-IP3	Perioperative Care: Venous Thromboembolism (VTE) Prophylaxis	Reported	0	0	0	491	0	766	0	64.10%	0	1
PY1	DPH	Natividad Medical Center	Q-IP4	Prevention of Central Venous Catheter (CVC) - Related Bloodstream Infections	Reported	0	0	0	376	0	467	0	80.50%	0	1
PY1	DPH	Natividad Medical Center	Q-IP5	Appropriate Treatment of Methicillin-Sensitive Staphylococcus Aureus (MSSA) Bacteremia	Not Reported	None	None	None	None	None	None	None	None	None	None
PY1	DPH	Natividad Medical Center	Q-IP6	Stroke: Discharged on Antithrombotic Therapy (TJC STK-2)	Not Reported	None	None	None	None	None	None	None	None	None	None
PY1	DPH	Natividad Medical Center	Q-RU1	Cardiac Stress Imaging Not Meeting Appropriate Use Criteria: Preoperative Evaluation in Low Risk Surgery Patients (QPP)	Reported	0	0	0	None	1	78	0	None	1	1
PY1	DPH	Natividad Medical Center	Q-RU2	Emergency Department Utilization of CT for Minor Blunt Head Trauma for Patients 18 Years and Older	Not Reported	None	None	None	None	None	None	None	None	None	None
PY1	DPH	Natividad Medical Center	Q-RU3	Emergency Department Utilization of CT for Minor Blunt Head Trauma for Patients Aged 2 to 17 years old	Not Reported	None	None	None	None	None	None	None	None	None	None
PY1	DPH	Natividad Medical Center	Q-RU4	Unplanned Reoperation within the 30 Day Postoperative Period (QPP)	No Data Entered	None	None	None	None	None	None	None	None	None	None
PY1	DPH	Natividad Medical Center	Q-RU5	Concurrent Use of Opioids and Benzodiazepines	Reported	N/A	3	N/A	N/A	3	N/A	3	N/A	3	1
PY1	DPH	Natividad Medical Center	Q-RU5	? RATE #1	Reported	0	0	0	13	0	185	0	7.00%	0	1
PY1	DPH	Natividad Medical Center	Q-RU5	? RATE #2	Reported	0	0	0	50	0	548	0	9.10%	0	1
PY1	DPH	Riverside University Health System	Q-PC1	Comprehensive Diabetes Care: A1C Control (<8%) (CDC-H8)	Reported	0	0	0	601	0	1157	0	51.90%	0	1
PY1	DPH	Riverside University Health System	Q-PC2	Comprehensive Diabetes Care: Eye Exam (CDC-E)	Reported	0	0	0	132	0	1157	0	11.40%	0	1
PY1	DPH	Riverside University Health System	Q-PC3	Comprehensive Diabetes Care: Blood Pressure Control (CDC-BP)	Reported	0	0	0	692	0	1157	0	59.80%	0	1
PY1	DPH	Riverside University Health System	Q-PC4	Asthma Medication Ratio (AMR)	Not Reported	None	None	None	None	None	None	None	None	None	None
PY1	DPH	Riverside University Health System	Q-PC5	Medication Reconciliation Post Discharge (MRP)	Reported	0	0	0	511	0	782	0	65.40%	0	1
PY1	DPH	Riverside University Health System	Q-PC6	7 Day Post-Discharge Follow-Up for High Risk Beneficiaries	Reported	0	0	0	77	0	239	0	32.20%	0	1
PY1	DPH	Riverside University Health System	Q-PC7	Children and Adolescent Access to PCP (CAP)	Not Reported	None	None	None	None	None	None	None	None	None	None
PY1	DPH	Riverside University Health System	Q-PC8	Childhood Immunization Status (CIS) Combination 3	Not Reported	None	None	None	None	None	None	None	None	None	None
PY1	DPH	Riverside University Health System	Q-PC9	Immunization for Adolescents (IMA) Combination 2	Reported	0	0	0	34	0	101	0	33.70%	0	1
PY1	DPH	Riverside University Health System	Q-SC1	Atrial Fibrillation and Atrial Flutter: Chronic Anticoagulation Therapy	Reported	0	0	0	77	0	142	0	54.20%	0	1
PY1	DPH	Riverside University Health System	Q-SC2	Coronary Artery Disease (CAD): Antiplatelet Therapy	Reported	0	0	0	727	0	849	0	85.60%	0	1
PY1	DPH	Riverside University Health System	Q-SC3	Coronary Artery Disease (CAD): Angiotensin-Converting Enzyme (ACE) Inhibitor or Angiotensin-Receptor Blocker (ARB) Therapy - Diabetes or Left Ventricular Systolic Dysfunction (LVEF < 40%)	Reported	0	0	0	386	0	445	0	86.70%	0	1
PY1	DPH	Riverside University Health System	Q-SC4	Coronary Artery Disease (CAD): Beta-Blocker Therapy-Prior Myocardial Infarction (MI) or Left Ventricular Systolic Dysfunction (LVEF <40%)	Reported	0	0	0	227	0	342	0	66.40%	0	1
PY1	DPH	Riverside University Health System	Q-SC5	Heart Failure (HF): Angiotensin-Converting Enzyme (ACE) Inhibitor or Angiotensin-Receptor Blocker (ARB) Therapy for Left Ventricular Systolic Dysfunction	Reported	0	0	0	315	0	374	0	84.20%	0	1
PY1	DPH	Riverside University Health System	Q-SC6	Heart Failure (HF): Beta-Blocker Therapy for Left Ventricular Systolic Dysfunction	Reported	0	0	0	315	0	389	0	81.00%	0	1
PY1	DPH	Riverside University Health System	Q-IP1	Surgical Site Infection (SSI) (Reported as SIR)	Reported	0	0	0	12	0	9.855	0	1.2177	0	1
PY1	DPH	Riverside University Health System	Q-IP2	Perioperative Care: Selection of Prophylactic Antibiotic - 1st OR 2nd Generation Cephalosporin	Reported	0	0	0	326	0	433	0	75.30%	0	1
PY1	DPH	Riverside University Health System	Q-IP3	Perioperative Care: Venous Thromboembolism (VTE) Prophylaxis	Reported	0	0	0	43	0	418	0	10.30%	0	1
PY1	DPH	Riverside University Health System	Q-IP4	Prevention of Central Venous Catheter (CVC) - Related Bloodstream Infections	Reported	0	0	0	238	0	773	0	30.80%	0	1
PY1	DPH	Riverside University Health System	Q-IP5	Appropriate Treatment of Methicillin-Sensitive Staphylococcus Aureus (MSSA) Bacteremia	Not Reported	None	None	None	None	None	None	None	None	None	None
PY1	DPH	Riverside University Health System	Q-IP6	Stroke: Discharged on Antithrombotic Therapy (TJC STK-2)	Not Reported	None	None	None	None	None	None	None	None	None	None
PY1	DPH	Riverside University Health System	Q-RU1	Cardiac Stress Imaging Not Meeting Appropriate Use Criteria: Preoperative Evaluation in Low Risk Surgery Patients (QPP)	Reported	0	0	0	0	0	68	0	0.00%	0	1
PY1	DPH	Riverside University Health System	Q-RU2	Emergency Department Utilization of CT for Minor Blunt Head Trauma for Patients 18 Years and Older	Reported	0	0	0	31	0	39	0	79.50%	0	1
PY1	DPH	Riverside University Health System	Q-RU3	Emergency Department Utilization of CT for Minor Blunt Head Trauma for Patients Aged 2 to 17 years old	Not Reported	None	None	None	None	None	None	None	None	None	None
PY1	DPH	Riverside University Health System	Q-RU4	Unplanned Reoperation within the 30 Day Postoperative Period (QPP)	No Data Entered	None	None	None	None	None	None	None	None	None	None
PY1	DPH	Riverside University Health System	Q-RU5	Concurrent Use of Opioids and Benzodiazepines	Reported	N/A	3	N/A	N/A	3	N/A	3	N/A	3	1
PY1	DPH	Riverside University Health System	Q-RU5	? RATE #1	Reported	0	0	0	24	0	652	0	3.70%	0	1
PY1	DPH	Riverside University Health System	Q-RU5	? RATE #2	Reported	0	0	0	38	0	844	0	4.50%	0	1
PY1	DPH	San Francisco General Hospital	Q-PC1	Comprehensive Diabetes Care: A1C Control (<8%) (CDC-H8)	Reported	0	0	0	2060	0	3329	0	61.90%	0	1
PY1	DPH	San Francisco General Hospital	Q-PC2	Comprehensive Diabetes Care: Eye Exam (CDC-E)	Reported	0	0	0	2205	0	3329	0	66.20%	0	1
PY1	DPH	San Francisco General Hospital	Q-PC3	Comprehensive Diabetes Care: Blood Pressure Control (CDC-BP)	Reported	0	0	0	2517	0	3329	0	75.60%	0	1
PY1	DPH	San Francisco General Hospital	Q-PC4	Asthma Medication Ratio (AMR)	Not Reported	None	None	None	None	None	None	None	None	None	None
PY1	DPH	San Francisco General Hospital	Q-PC5	Medication Reconciliation Post Discharge (MRP)	Reported	0	0	0	1551	0	2762	0	56.20%	0	1
PY1	DPH	San Francisco General Hospital	Q-PC6	7 Day Post-Discharge Follow-Up for High Risk Beneficiaries	Reported	0	0	0	235	0	476	0	49.40%	0	1
PY1	DPH	San Francisco General Hospital	Q-PC7	Children and Adolescent Access to PCP (CAP)	Reported	N/A	3	N/A	None	None	None	None	None	None	1
PY1	DPH	San Francisco General Hospital	Q-PC7	? 12-24 Months	Reported	0	0	0	344	0	355	0	96.90%	0	1
PY1	DPH	San Francisco General Hospital	Q-PC7	? 25 Months-6 Years	Reported	0	0	0	1949	0	2187	0	89.10%	0	1
PY1	DPH	San Francisco General Hospital	Q-PC7	? 7-11 Years	Reported	0	0	0	1518	0	1693	0	89.70%	0	1
PY1	DPH	San Francisco General Hospital	Q-PC7	? 12-19 Years	Reported	0	0	0	1643	0	1858	0	88.40%	0	1
PY1	DPH	San Francisco General Hospital	Q-PC8	Childhood Immunization Status (CIS) Combination 3	Reported	0	0	0	404	0	448	0	90.20%	0	1
PY1	DPH	San Francisco General Hospital	Q-PC9	Immunization for Adolescents (IMA) Combination 2	Reported	0	0	0	187	0	286	0	65.40%	0	1
PY1	DPH	San Francisco General Hospital	Q-SC1	Atrial Fibrillation and Atrial Flutter: Chronic Anticoagulation Therapy	Reported	0	0	0	162	0	206	0	78.60%	0	1
PY1	DPH	San Francisco General Hospital	Q-SC2	Coronary Artery Disease (CAD): Antiplatelet Therapy	Reported	0	0	0	809	0	862	0	93.90%	0	1
PY1	DPH	San Francisco General Hospital	Q-SC3	Coronary Artery Disease (CAD): Angiotensin-Converting Enzyme (ACE) Inhibitor or Angiotensin-Receptor Blocker (ARB) Therapy - Diabetes or Left Ventricular Systolic Dysfunction (LVEF < 40%)	Reported	0	0	0	446	0	516	0	86.40%	0	1
PY1	DPH	San Francisco General Hospital	Q-SC4	Coronary Artery Disease (CAD): Beta-Blocker Therapy-Prior Myocardial Infarction (MI) or Left Ventricular Systolic Dysfunction (LVEF <40%)	Reported	0	0	0	198	0	206	0	96.10%	0	1
PY1	DPH	San Francisco General Hospital	Q-SC5	Heart Failure (HF): Angiotensin-Converting Enzyme (ACE) Inhibitor or Angiotensin-Receptor Blocker (ARB) Therapy for Left Ventricular Systolic Dysfunction	Reported	0	0	0	340	0	396	0	85.90%	0	1
PY1	DPH	San Francisco General Hospital	Q-SC6	Heart Failure (HF): Beta-Blocker Therapy for Left Ventricular Systolic Dysfunction	Reported	0	0	0	378	0	401	0	94.30%	0	1
PY1	DPH	San Francisco General Hospital	Q-IP1	Surgical Site Infection (SSI) (Reported as SIR)	Not Reported	None	None	None	None	None	None	None	None	None	None
PY1	DPH	San Francisco General Hospital	Q-IP2	Perioperative Care: Selection of Prophylactic Antibiotic - 1st OR 2nd Generation Cephalosporin	Reported	0	0	0	367	0	385	0	95.30%	0	1
PY1	DPH	San Francisco General Hospital	Q-IP3	Perioperative Care: Venous Thromboembolism (VTE) Prophylaxis	Reported	0	0	0	361	0	373	0	96.80%	0	1
PY1	DPH	San Francisco General Hospital	Q-IP4	Prevention of Central Venous Catheter (CVC) - Related Bloodstream Infections	Reported	0	0	0	0	0	569	0	0.00%	0	1
PY1	DPH	San Francisco General Hospital	Q-IP5	Appropriate Treatment of Methicillin-Sensitive Staphylococcus Aureus (MSSA) Bacteremia	Reported	0	0	0	31	0	31	0	100.00%	0	1
PY1	DPH	San Francisco General Hospital	Q-IP6	Stroke: Discharged on Antithrombotic Therapy (TJC STK-2)	Reported	0	0	0	90	0	90	0	100.00%	0	1
PY1	DPH	San Francisco General Hospital	Q-RU1	Cardiac Stress Imaging Not Meeting Appropriate Use Criteria: Preoperative Evaluation in Low Risk Surgery Patients (QPP)	Reported	0	0	0	None	1	155	0	None	1	1
PY1	DPH	San Francisco General Hospital	Q-RU2	Emergency Department Utilization of CT for Minor Blunt Head Trauma for Patients 18 Years and Older	Not Reported	None	None	None	None	None	None	None	None	None	None
PY1	DPH	San Francisco General Hospital	Q-RU3	Emergency Department Utilization of CT for Minor Blunt Head Trauma for Patients Aged 2 to 17 years old	Not Reported	None	None	None	None	None	None	None	None	None	None
PY1	DPH	San Francisco General Hospital	Q-RU4	Unplanned Reoperation within the 30 Day Postoperative Period (QPP)	Not Reported	None	None	None	None	None	None	None	None	None	None
PY1	DPH	San Francisco General Hospital	Q-RU5	Concurrent Use of Opioids and Benzodiazepines	Not Reported	None	None	None	None	None	None	None	None	None	None
PY1	DPH	San Joaquin General Hospital	Q-PC1	Comprehensive Diabetes Care: A1C Control (<8%) (CDC-H8)	Reported	0	0	0	274	0	548	0	50.00%	0	1
PY1	DPH	San Joaquin General Hospital	Q-PC2	Comprehensive Diabetes Care: Eye Exam (CDC-E)	Reported	0	0	0	259	0	548	0	47.30%	0	1
PY1	DPH	San Joaquin General Hospital	Q-PC3	Comprehensive Diabetes Care: Blood Pressure Control (CDC-BP)	Reported	0	0	0	396	0	548	0	72.30%	0	1
PY1	DPH	San Joaquin General Hospital	Q-PC4	Asthma Medication Ratio (AMR)	Reported	0	0	0	36	0	50	0	72.00%	0	1
PY1	DPH	San Joaquin General Hospital	Q-PC5	Medication Reconciliation Post Discharge (MRP)	Reported	0	0	0	104	0	235	0	44.30%	0	1
PY1	DPH	San Joaquin General Hospital	Q-PC6	7 Day Post-Discharge Follow-Up for High Risk Beneficiaries	Reported	0	0	0	125	0	228	0	54.80%	0	1
PY1	DPH	San Joaquin General Hospital	Q-PC7	Children and Adolescent Access to PCP (CAP)	Reported	N/A	3	N/A	None	None	None	None	None	None	1
PY1	DPH	San Joaquin General Hospital	Q-PC7	? 12-24 Months	Reported	0	0	0	381	0	413	0	92.30%	0	1
PY1	DPH	San Joaquin General Hospital	Q-PC7	? 25 Months-6 Years	Reported	0	0	0	2025	0	2686	0	75.40%	0	1
PY1	DPH	San Joaquin General Hospital	Q-PC7	? 7-11 Years	Reported	0	0	0	2081	0	2924	0	71.20%	0	1
PY1	DPH	San Joaquin General Hospital	Q-PC7	? 12-19 Years	Reported	0	0	0	2844	0	4202	0	67.70%	0	1
PY1	DPH	San Joaquin General Hospital	Q-PC8	Childhood Immunization Status (CIS) Combination 3	Reported	0	0	0	134	0	184	0	72.80%	0	1
PY1	DPH	San Joaquin General Hospital	Q-PC9	Immunization for Adolescents (IMA) Combination 2	Reported	0	0	0	69	0	132	0	52.30%	0	1
PY1	DPH	San Joaquin General Hospital	Q-SC1	Atrial Fibrillation and Atrial Flutter: Chronic Anticoagulation Therapy	Reported	0	0	0	66	0	73	0	90.40%	0	1
PY1	DPH	San Joaquin General Hospital	Q-SC2	Coronary Artery Disease (CAD): Antiplatelet Therapy	Reported	0	0	0	134	0	161	0	83.20%	0	1
PY1	DPH	San Joaquin General Hospital	Q-SC3	Coronary Artery Disease (CAD): Angiotensin-Converting Enzyme (ACE) Inhibitor or Angiotensin-Receptor Blocker (ARB) Therapy - Diabetes or Left Ventricular Systolic Dysfunction (LVEF < 40%)	Reported	0	0	0	105	0	121	0	86.80%	0	1
PY1	DPH	San Joaquin General Hospital	Q-SC4	Coronary Artery Disease (CAD): Beta-Blocker Therapy-Prior Myocardial Infarction (MI) or Left Ventricular Systolic Dysfunction (LVEF <40%)	Reported	0	0	0	87	0	104	0	83.70%	0	1
PY1	DPH	San Joaquin General Hospital	Q-SC5	Heart Failure (HF): Angiotensin-Converting Enzyme (ACE) Inhibitor or Angiotensin-Receptor Blocker (ARB) Therapy for Left Ventricular Systolic Dysfunction	Reported	0	0	0	61	0	80	0	76.30%	0	1
PY1	DPH	San Joaquin General Hospital	Q-SC6	Heart Failure (HF): Beta-Blocker Therapy for Left Ventricular Systolic Dysfunction	Reported	0	0	0	61	0	80	0	76.30%	0	1
PY1	DPH	San Joaquin General Hospital	Q-IP1	Surgical Site Infection (SSI) (Reported as SIR)	Not Reported	None	None	None	None	None	None	None	None	None	None
PY1	DPH	San Joaquin General Hospital	Q-IP2	Perioperative Care: Selection of Prophylactic Antibiotic - 1st OR 2nd Generation Cephalosporin	Reported	0	0	0	63	0	88	0	71.60%	0	1
PY1	DPH	San Joaquin General Hospital	Q-IP3	Perioperative Care: Venous Thromboembolism (VTE) Prophylaxis	Reported	0	0	0	82	0	98	0	83.70%	0	1
PY1	DPH	San Joaquin General Hospital	Q-IP4	Prevention of Central Venous Catheter (CVC) - Related Bloodstream Infections	Reported	0	0	0	45	0	48	0	93.80%	0	1
PY1	DPH	San Joaquin General Hospital	Q-IP5	Appropriate Treatment of Methicillin-Sensitive Staphylococcus Aureus (MSSA) Bacteremia	Reported	0	0	0	12	0	None	4	None	4	1
PY1	DPH	San Joaquin General Hospital	Q-IP6	Stroke: Discharged on Antithrombotic Therapy (TJC STK-2)	Reported	0	0	0	68	0	86	0	79.10%	0	1
PY1	DPH	San Joaquin General Hospital	Q-RU1	Cardiac Stress Imaging Not Meeting Appropriate Use Criteria: Preoperative Evaluation in Low Risk Surgery Patients (QPP)	Not Reported	None	None	None	None	None	None	None	None	None	None
PY1	DPH	San Joaquin General Hospital	Q-RU2	Emergency Department Utilization of CT for Minor Blunt Head Trauma for Patients 18 Years and Older	Not Reported	None	None	None	None	None	None	None	None	None	None
PY1	DPH	San Joaquin General Hospital	Q-RU3	Emergency Department Utilization of CT for Minor Blunt Head Trauma for Patients Aged 2 to 17 years old	Not Reported	None	None	None	None	None	None	None	None	None	None
PY1	DPH	San Joaquin General Hospital	Q-RU4	Unplanned Reoperation within the 30 Day Postoperative Period (QPP)	Not Reported	None	None	None	None	None	None	None	None	None	None
PY1	DPH	San Joaquin General Hospital	Q-RU5	Concurrent Use of Opioids and Benzodiazepines	Not Reported	None	None	None	None	None	None	None	None	None	None
PY1	DPH	Santa Clara Valley Medical Center	Q-PC1	Comprehensive Diabetes Care: A1C Control (<8%) (CDC-H8)	Reported	0	0	0	2867	0	5224	0	54.90%	0	1
PY1	DPH	Santa Clara Valley Medical Center	Q-PC2	Comprehensive Diabetes Care: Eye Exam (CDC-E)	Reported	0	0	0	2524	0	5224	0	48.30%	0	1
PY1	DPH	Santa Clara Valley Medical Center	Q-PC3	Comprehensive Diabetes Care: Blood Pressure Control (CDC-BP)	Reported	0	0	0	3526	0	5224	0	67.50%	0	1
PY1	DPH	Santa Clara Valley Medical Center	Q-PC4	Asthma Medication Ratio (AMR)	Not Reported	None	None	None	None	None	None	None	None	None	None
PY1	DPH	Santa Clara Valley Medical Center	Q-PC5	Medication Reconciliation Post Discharge (MRP)	Reported	0	0	0	213	0	568	0	37.50%	0	1
PY1	DPH	Santa Clara Valley Medical Center	Q-PC6	7 Day Post-Discharge Follow-Up for High Risk Beneficiaries	Reported	0	0	0	137	0	1428	0	9.60%	0	1
PY1	DPH	Santa Clara Valley Medical Center	Q-PC7	Children and Adolescent Access to PCP (CAP)	Not Reported	None	None	None	None	None	None	None	None	None	None
PY1	DPH	Santa Clara Valley Medical Center	Q-PC8	Childhood Immunization Status (CIS) Combination 3	Reported	0	0	0	988	0	1305	0	75.70%	0	1
PY1	DPH	Santa Clara Valley Medical Center	Q-PC9	Immunization for Adolescents (IMA) Combination 2	Reported	0	0	0	484	0	949	0	51.00%	0	1
PY1	DPH	Santa Clara Valley Medical Center	Q-SC1	Atrial Fibrillation and Atrial Flutter: Chronic Anticoagulation Therapy	Reported	0	0	0	278	0	425	0	65.40%	0	1
PY1	DPH	Santa Clara Valley Medical Center	Q-SC2	Coronary Artery Disease (CAD): Antiplatelet Therapy	Reported	0	0	0	1284	0	1530	0	83.90%	0	1
PY1	DPH	Santa Clara Valley Medical Center	Q-SC3	Coronary Artery Disease (CAD): Angiotensin-Converting Enzyme (ACE) Inhibitor or Angiotensin-Receptor Blocker (ARB) Therapy - Diabetes or Left Ventricular Systolic Dysfunction (LVEF < 40%)	Reported	0	0	0	560	0	780	0	71.80%	0	1
PY1	DPH	Santa Clara Valley Medical Center	Q-SC4	Coronary Artery Disease (CAD): Beta-Blocker Therapy-Prior Myocardial Infarction (MI) or Left Ventricular Systolic Dysfunction (LVEF <40%)	Reported	0	0	0	158	0	447	0	35.40%	0	1
PY1	DPH	Santa Clara Valley Medical Center	Q-SC5	Heart Failure (HF): Angiotensin-Converting Enzyme (ACE) Inhibitor or Angiotensin-Receptor Blocker (ARB) Therapy for Left Ventricular Systolic Dysfunction	Reported	0	0	0	0	0	0.001	0	0.00%	0	1
PY1	DPH	Santa Clara Valley Medical Center	Q-SC6	Heart Failure (HF): Beta-Blocker Therapy for Left Ventricular Systolic Dysfunction	Reported	0	0	0	0	0	0.001	0	0.00%	0	1
PY1	DPH	Santa Clara Valley Medical Center	Q-IP1	Surgical Site Infection (SSI) (Reported as SIR)	Reported	0	0	0	13	0	12.178	0	1.0675	0	1
PY1	DPH	Santa Clara Valley Medical Center	Q-IP2	Perioperative Care: Selection of Prophylactic Antibiotic - 1st OR 2nd Generation Cephalosporin	Reported	0	0	0	971	0	1352	0	71.80%	0	1
PY1	DPH	Santa Clara Valley Medical Center	Q-IP3	Perioperative Care: Venous Thromboembolism (VTE) Prophylaxis	Reported	0	0	0	1253	0	1304	0	96.10%	0	1
PY1	DPH	Santa Clara Valley Medical Center	Q-IP4	Prevention of Central Venous Catheter (CVC) - Related Bloodstream Infections	Reported	0	0	0	93	0	791	0	11.80%	0	1
PY1	DPH	Santa Clara Valley Medical Center	Q-IP5	Appropriate Treatment of Methicillin-Sensitive Staphylococcus Aureus (MSSA) Bacteremia	Reported	0	0	0	29	0	34	0	85.30%	0	1
PY1	DPH	Santa Clara Valley Medical Center	Q-IP6	Stroke: Discharged on Antithrombotic Therapy (TJC STK-2)	Reported	0	0	0	81	0	84	0	96.40%	0	1
PY1	DPH	Santa Clara Valley Medical Center	Q-RU1	Cardiac Stress Imaging Not Meeting Appropriate Use Criteria: Preoperative Evaluation in Low Risk Surgery Patients (QPP)	Not Reported	None	None	None	None	None	None	None	None	None	None
PY1	DPH	Santa Clara Valley Medical Center	Q-RU2	Emergency Department Utilization of CT for Minor Blunt Head Trauma for Patients 18 Years and Older	Not Reported	None	None	None	None	None	None	None	None	None	None
PY1	DPH	Santa Clara Valley Medical Center	Q-RU3	Emergency Department Utilization of CT for Minor Blunt Head Trauma for Patients Aged 2 to 17 years old	Not Reported	None	None	None	None	None	None	None	None	None	None
PY1	DPH	Santa Clara Valley Medical Center	Q-RU4	Unplanned Reoperation within the 30 Day Postoperative Period (QPP)	No Data Entered	None	None	None	None	None	None	None	None	None	None
PY1	DPH	Santa Clara Valley Medical Center	Q-RU5	Concurrent Use of Opioids and Benzodiazepines	Reported	N/A	3	N/A	N/A	3	N/A	3	N/A	3	1
PY1	DPH	Santa Clara Valley Medical Center	Q-RU5	? RATE #1	Reported	0	0	0	122	0	1866	0	6.50%	0	1
PY1	DPH	Santa Clara Valley Medical Center	Q-RU5	? RATE #2	Reported	0	0	0	145	0	2033	0	7.10%	0	1
PY1	DPH	San Mateo Medical Center	Q-PC1	Comprehensive Diabetes Care: A1C Control (<8%) (CDC-H8)	Reported	0	0	0	1193	0	1891	0	63.10%	0	1
PY1	DPH	San Mateo Medical Center	Q-PC2	Comprehensive Diabetes Care: Eye Exam (CDC-E)	Reported	0	0	0	1861	0	1891	0	98.40%	0	1
PY1	DPH	San Mateo Medical Center	Q-PC3	Comprehensive Diabetes Care: Blood Pressure Control (CDC-BP)	Reported	0	0	0	1396	0	1891	0	73.80%	0	1
PY1	DPH	San Mateo Medical Center	Q-PC4	Asthma Medication Ratio (AMR)	Reported	0	0	0	177	0	292	0	60.60%	0	1
PY1	DPH	San Mateo Medical Center	Q-PC5	Medication Reconciliation Post Discharge (MRP)	Reported	0	0	0	288	0	598	0	48.20%	0	1
PY1	DPH	San Mateo Medical Center	Q-PC6	7 Day Post-Discharge Follow-Up for High Risk Beneficiaries	Not Reported	None	None	None	None	None	None	None	None	None	None
PY1	DPH	San Mateo Medical Center	Q-PC7	Children and Adolescent Access to PCP (CAP)	Reported	N/A	3	N/A	None	None	None	None	None	None	1
PY1	DPH	San Mateo Medical Center	Q-PC7	? 12-24 Months	Reported	0	0	0	312	0	312	0	100.00%	0	1
PY1	DPH	San Mateo Medical Center	Q-PC7	? 25 Months-6 Years	Reported	0	0	0	2008	0	2202	0	91.20%	0	1
PY1	DPH	San Mateo Medical Center	Q-PC7	? 7-11 Years	Reported	0	0	0	1834	0	2147	0	85.40%	0	1
PY1	DPH	San Mateo Medical Center	Q-PC7	? 12-19 Years	Reported	0	0	0	2110	0	2659	0	79.40%	0	1
PY1	DPH	San Mateo Medical Center	Q-PC8	Childhood Immunization Status (CIS) Combination 3	Reported	0	0	0	190	0	281	0	67.60%	0	1
PY1	DPH	San Mateo Medical Center	Q-PC9	Immunization for Adolescents (IMA) Combination 2	Reported	0	0	0	175	0	264	0	66.30%	0	1
PY1	DPH	San Mateo Medical Center	Q-SC1	Atrial Fibrillation and Atrial Flutter: Chronic Anticoagulation Therapy	Reported	0	0	0	301	0	397	0	75.80%	0	1
PY1	DPH	San Mateo Medical Center	Q-SC2	Coronary Artery Disease (CAD): Antiplatelet Therapy	Reported	0	0	0	606	0	681	0	89.00%	0	1
PY1	DPH	San Mateo Medical Center	Q-SC3	Coronary Artery Disease (CAD): Angiotensin-Converting Enzyme (ACE) Inhibitor or Angiotensin-Receptor Blocker (ARB) Therapy - Diabetes or Left Ventricular Systolic Dysfunction (LVEF < 40%)	Reported	0	0	0	302	0	340	0	88.80%	0	1
PY1	DPH	San Mateo Medical Center	Q-SC4	Coronary Artery Disease (CAD): Beta-Blocker Therapy-Prior Myocardial Infarction (MI) or Left Ventricular Systolic Dysfunction (LVEF <40%)	Reported	0	0	0	143	0	159	0	89.90%	0	1
PY1	DPH	San Mateo Medical Center	Q-SC5	Heart Failure (HF): Angiotensin-Converting Enzyme (ACE) Inhibitor or Angiotensin-Receptor Blocker (ARB) Therapy for Left Ventricular Systolic Dysfunction	Reported	0	0	0	114	0	127	0	89.80%	0	1
PY1	DPH	San Mateo Medical Center	Q-SC6	Heart Failure (HF): Beta-Blocker Therapy for Left Ventricular Systolic Dysfunction	Reported	0	0	0	90	0	127	0	70.90%	0	1
PY1	DPH	San Mateo Medical Center	Q-IP1	Surgical Site Infection (SSI) (Reported as SIR)	Not Reported	None	None	None	None	None	None	None	None	None	None
PY1	DPH	San Mateo Medical Center	Q-IP2	Perioperative Care: Selection of Prophylactic Antibiotic - 1st OR 2nd Generation Cephalosporin	Reported	0	0	0	218	0	226	0	96.50%	0	1
PY1	DPH	San Mateo Medical Center	Q-IP3	Perioperative Care: Venous Thromboembolism (VTE) Prophylaxis	Reported	0	0	0	337	0	504	0	66.90%	0	1
PY1	DPH	San Mateo Medical Center	Q-IP4	Prevention of Central Venous Catheter (CVC) - Related Bloodstream Infections	Reported	0	0	0	57	0	125	0	45.60%	0	1
PY1	DPH	San Mateo Medical Center	Q-IP5	Appropriate Treatment of Methicillin-Sensitive Staphylococcus Aureus (MSSA) Bacteremia	Not Reported	None	None	None	None	None	None	None	None	None	None
PY1	DPH	San Mateo Medical Center	Q-IP6	Stroke: Discharged on Antithrombotic Therapy (TJC STK-2)	Not Reported	None	None	None	None	None	None	None	None	None	None
PY1	DPH	San Mateo Medical Center	Q-RU1	Cardiac Stress Imaging Not Meeting Appropriate Use Criteria: Preoperative Evaluation in Low Risk Surgery Patients (QPP)	Reported	0	0	0	None	1	229	0	None	1	1
PY1	DPH	San Mateo Medical Center	Q-RU2	Emergency Department Utilization of CT for Minor Blunt Head Trauma for Patients 18 Years and Older	Reported	0	0	0	63	0	78	0	80.80%	0	1
PY1	DPH	San Mateo Medical Center	Q-RU3	Emergency Department Utilization of CT for Minor Blunt Head Trauma for Patients Aged 2 to 17 years old	Not Reported	None	None	None	None	None	None	None	None	None	None
PY1	DPH	San Mateo Medical Center	Q-RU4	Unplanned Reoperation within the 30 Day Postoperative Period (QPP)	Not Reported	None	None	None	None	None	None	None	None	None	None
PY1	DPH	San Mateo Medical Center	Q-RU5	Concurrent Use of Opioids and Benzodiazepines	Reported	N/A	3	N/A	N/A	3	N/A	3	N/A	3	1
PY1	DPH	San Mateo Medical Center	Q-RU5	? RATE #1	Reported	0	0	0	100	0	1298	0	7.70%	0	1
PY1	DPH	San Mateo Medical Center	Q-RU5	? RATE #2	Reported	0	0	0	167	0	1984	0	8.40%	0	1
PY1	DPH	UC Davis Medical Center	Q-PC1	Comprehensive Diabetes Care: A1C Control (<8%) (CDC-H8)	Reported	0	0	0	0	0	0.01	0	0.00%	0	1
PY1	DPH	UC Davis Medical Center	Q-PC2	Comprehensive Diabetes Care: Eye Exam (CDC-E)	Reported	0	0	0	0	0	0.01	0	0.00%	0	1
PY1	DPH	UC Davis Medical Center	Q-PC3	Comprehensive Diabetes Care: Blood Pressure Control (CDC-BP)	Reported	0	0	0	0	0	0.01	0	0.00%	0	1
PY1	DPH	UC Davis Medical Center	Q-PC4	Asthma Medication Ratio (AMR)	Not Reported	None	None	None	None	None	None	None	None	None	None
PY1	DPH	UC Davis Medical Center	Q-PC5	Medication Reconciliation Post Discharge (MRP)	Reported	0	0	0	34	0	44	0	77.30%	0	1
PY1	DPH	UC Davis Medical Center	Q-PC6	7 Day Post-Discharge Follow-Up for High Risk Beneficiaries	Reported	0	0	0	49	0	58	0	84.50%	0	1
PY1	DPH	UC Davis Medical Center	Q-PC7	Children and Adolescent Access to PCP (CAP)	Not Reported	None	None	None	None	None	None	None	None	None	None
PY1	DPH	UC Davis Medical Center	Q-PC8	Childhood Immunization Status (CIS) Combination 3	Not Reported	None	None	None	None	None	None	None	None	None	None
PY1	DPH	UC Davis Medical Center	Q-PC9	Immunization for Adolescents (IMA) Combination 2	Not Reported	None	None	None	None	None	None	None	None	None	None
PY1	DPH	UC Davis Medical Center	Q-SC1	Atrial Fibrillation and Atrial Flutter: Chronic Anticoagulation Therapy	Reported	0	0	0	None	1	None	1	None	1	1
PY1	DPH	UC Davis Medical Center	Q-SC2	Coronary Artery Disease (CAD): Antiplatelet Therapy	Reported	0	0	0	26	0	34	0	76.50%	0	1
PY1	DPH	UC Davis Medical Center	Q-SC3	Coronary Artery Disease (CAD): Angiotensin-Converting Enzyme (ACE) Inhibitor or Angiotensin-Receptor Blocker (ARB) Therapy - Diabetes or Left Ventricular Systolic Dysfunction (LVEF < 40%)	Reported	0	0	0	16	0	None	4	None	4	1
PY1	DPH	UC Davis Medical Center	Q-SC4	Coronary Artery Disease (CAD): Beta-Blocker Therapy-Prior Myocardial Infarction (MI) or Left Ventricular Systolic Dysfunction (LVEF <40%)	Reported	0	0	0	13	0	None	4	None	4	1
PY1	DPH	UC Davis Medical Center	Q-SC5	Heart Failure (HF): Angiotensin-Converting Enzyme (ACE) Inhibitor or Angiotensin-Receptor Blocker (ARB) Therapy for Left Ventricular Systolic Dysfunction	Reported	0	0	0	None	1	None	1	None	1	1
PY1	DPH	UC Davis Medical Center	Q-SC6	Heart Failure (HF): Beta-Blocker Therapy for Left Ventricular Systolic Dysfunction	Reported	0	0	0	None	1	None	1	None	1	1
PY1	DPH	UC Davis Medical Center	Q-IP1	Surgical Site Infection (SSI) (Reported as SIR)	Reported	0	0	0	29	0	31.77	0	0.9128	0	1
PY1	DPH	UC Davis Medical Center	Q-IP2	Perioperative Care: Selection of Prophylactic Antibiotic - 1st OR 2nd Generation Cephalosporin	Reported	0	0	0	464	0	546	0	85.00%	0	1
PY1	DPH	UC Davis Medical Center	Q-IP3	Perioperative Care: Venous Thromboembolism (VTE) Prophylaxis	Reported	0	0	0	807	0	819	0	98.50%	0	1
PY1	DPH	UC Davis Medical Center	Q-IP4	Prevention of Central Venous Catheter (CVC) - Related Bloodstream Infections	Reported	0	0	0	143	0	269	0	53.20%	0	1
PY1	DPH	UC Davis Medical Center	Q-IP5	Appropriate Treatment of Methicillin-Sensitive Staphylococcus Aureus (MSSA) Bacteremia	Reported	0	0	0	23	0	None	4	None	4	1
PY1	DPH	UC Davis Medical Center	Q-IP6	Stroke: Discharged on Antithrombotic Therapy (TJC STK-2)	Reported	0	0	0	37	0	37	0	100.00%	0	1
PY1	DPH	UC Davis Medical Center	Q-RU1	Cardiac Stress Imaging Not Meeting Appropriate Use Criteria: Preoperative Evaluation in Low Risk Surgery Patients (QPP)	Reported	0	0	0	0	0	None	4	None	4	1
PY1	DPH	UC Davis Medical Center	Q-RU2	Emergency Department Utilization of CT for Minor Blunt Head Trauma for Patients 18 Years and Older	Reported	0	0	0	191	0	217	0	88.00%	0	1
PY1	DPH	UC Davis Medical Center	Q-RU3	Emergency Department Utilization of CT for Minor Blunt Head Trauma for Patients Aged 2 to 17 years old	Reported	0	0	0	14	0	113	0	12.40%	0	1
PY1	DPH	UC Davis Medical Center	Q-RU4	Unplanned Reoperation within the 30 Day Postoperative Period (QPP)	No Data Entered	None	None	None	None	None	None	None	None	None	None
PY1	DPH	UC Davis Medical Center	Q-RU5	Concurrent Use of Opioids and Benzodiazepines	Not Reported	None	None	None	None	None	None	None	None	None	None
PY1	DPH	UC Irvine Medical Center	Q-PC1	Comprehensive Diabetes Care: A1C Control (<8%) (CDC-H8)	Reported	0	0	0	448	0	1004	0	44.60%	0	1
PY1	DPH	UC Irvine Medical Center	Q-PC2	Comprehensive Diabetes Care: Eye Exam (CDC-E)	Reported	0	0	0	106	0	1004	0	10.60%	0	1
PY1	DPH	UC Irvine Medical Center	Q-PC3	Comprehensive Diabetes Care: Blood Pressure Control (CDC-BP)	Reported	0	0	0	652	0	1004	0	64.90%	0	1
PY1	DPH	UC Irvine Medical Center	Q-PC4	Asthma Medication Ratio (AMR)	Reported	0	0	0	32	0	63	0	50.80%	0	1
PY1	DPH	UC Irvine Medical Center	Q-PC5	Medication Reconciliation Post Discharge (MRP)	Reported	0	0	0	287	0	534	0	53.80%	0	1
PY1	DPH	UC Irvine Medical Center	Q-PC6	7 Day Post-Discharge Follow-Up for High Risk Beneficiaries	Reported	0	0	0	31	0	77	0	40.30%	0	1
PY1	DPH	UC Irvine Medical Center	Q-PC7	Children and Adolescent Access to PCP (CAP)	Reported	N/A	3	N/A	None	None	None	None	None	None	1
PY1	DPH	UC Irvine Medical Center	Q-PC7	? 12-24 Months	Reported	0	0	0	144	0	149	0	96.60%	0	1
PY1	DPH	UC Irvine Medical Center	Q-PC7	? 25 Months-6 Years	Reported	0	0	0	516	0	637	0	81.00%	0	1
PY1	DPH	UC Irvine Medical Center	Q-PC7	? 7-11 Years	Reported	0	0	0	545	0	646	0	84.40%	0	1
PY1	DPH	UC Irvine Medical Center	Q-PC7	? 12-19 Years	Reported	0	0	0	1185	0	1431	0	82.80%	0	1
PY1	DPH	UC Irvine Medical Center	Q-PC8	Childhood Immunization Status (CIS) Combination 3	Reported	0	0	0	104	0	145	0	71.70%	0	1
PY1	DPH	UC Irvine Medical Center	Q-PC9	Immunization for Adolescents (IMA) Combination 2	Not Reported	None	None	None	None	None	None	None	None	None	None
PY1	DPH	UC Irvine Medical Center	Q-SC1	Atrial Fibrillation and Atrial Flutter: Chronic Anticoagulation Therapy	Reported	0	0	0	38	0	52	0	73.10%	0	1
PY1	DPH	UC Irvine Medical Center	Q-SC2	Coronary Artery Disease (CAD): Antiplatelet Therapy	Reported	0	0	0	205	0	259	0	79.20%	0	1
PY1	DPH	UC Irvine Medical Center	Q-SC3	Coronary Artery Disease (CAD): Angiotensin-Converting Enzyme (ACE) Inhibitor or Angiotensin-Receptor Blocker (ARB) Therapy - Diabetes or Left Ventricular Systolic Dysfunction (LVEF < 40%)	Reported	0	0	0	146	0	174	0	83.90%	0	1
PY1	DPH	UC Irvine Medical Center	Q-SC4	Coronary Artery Disease (CAD): Beta-Blocker Therapy-Prior Myocardial Infarction (MI) or Left Ventricular Systolic Dysfunction (LVEF <40%)	Not Reported	None	None	None	None	None	None	None	None	None	None
PY1	DPH	UC Irvine Medical Center	Q-SC5	Heart Failure (HF): Angiotensin-Converting Enzyme (ACE) Inhibitor or Angiotensin-Receptor Blocker (ARB) Therapy for Left Ventricular Systolic Dysfunction	Reported	0	0	0	90	0	111	0	81.10%	0	1
PY1	DPH	UC Irvine Medical Center	Q-SC6	Heart Failure (HF): Beta-Blocker Therapy for Left Ventricular Systolic Dysfunction	Reported	0	0	0	100	0	120	0	83.30%	0	1
PY1	DPH	UC Irvine Medical Center	Q-IP1	Surgical Site Infection (SSI) (Reported as SIR)	Reported	0	0	0	26	0	25.746	0	1.0099	0	1
PY1	DPH	UC Irvine Medical Center	Q-IP2	Perioperative Care: Selection of Prophylactic Antibiotic - 1st OR 2nd Generation Cephalosporin	Reported	0	0	0	764	0	1364	0	56.00%	0	1
PY1	DPH	UC Irvine Medical Center	Q-IP3	Perioperative Care: Venous Thromboembolism (VTE) Prophylaxis	Reported	0	0	0	550	0	1320	0	41.70%	0	1
PY1	DPH	UC Irvine Medical Center	Q-IP4	Prevention of Central Venous Catheter (CVC) - Related Bloodstream Infections	Reported	0	0	0	28	0	1093	0	2.60%	None	1
PY1	DPH	UC Irvine Medical Center	Q-IP5	Appropriate Treatment of Methicillin-Sensitive Staphylococcus Aureus (MSSA) Bacteremia	Reported	0	0	0	20	0	None	4	None	4	1
PY1	DPH	UC Irvine Medical Center	Q-IP6	Stroke: Discharged on Antithrombotic Therapy (TJC STK-2)	Reported	0	0	0	71	0	77	0	92.20%	0	1
PY1	DPH	UC Irvine Medical Center	Q-RU1	Cardiac Stress Imaging Not Meeting Appropriate Use Criteria: Preoperative Evaluation in Low Risk Surgery Patients (QPP)	Not Reported	None	None	None	None	None	None	None	None	None	None
PY1	DPH	UC Irvine Medical Center	Q-RU2	Emergency Department Utilization of CT for Minor Blunt Head Trauma for Patients 18 Years and Older	Reported	0	0	0	101	0	565	0	17.90%	0	1
PY1	DPH	UC Irvine Medical Center	Q-RU3	Emergency Department Utilization of CT for Minor Blunt Head Trauma for Patients Aged 2 to 17 years old	Reported	0	0	0	None	1	68	0	None	1	1
PY1	DPH	UC Irvine Medical Center	Q-RU4	Unplanned Reoperation within the 30 Day Postoperative Period (QPP)	No Data Entered	None	None	None	None	None	None	None	None	None	None
PY1	DPH	UC Irvine Medical Center	Q-RU5	Concurrent Use of Opioids and Benzodiazepines	Reported	N/A	3	N/A	N/A	3	N/A	3	N/A	3	1
PY1	DPH	UC Irvine Medical Center	Q-RU5	? RATE #1	Reported	0	0	0	16	0	100	0	16.00%	0	1
PY1	DPH	UC Irvine Medical Center	Q-RU5	? RATE #2	Reported	0	0	0	44	0	397	0	11.10%	0	1
PY1	DPH	UC Los Angeles Medical Center	Q-PC1	Comprehensive Diabetes Care: A1C Control (<8%) (CDC-H8)	Reported	0	0	0	52	0	92	0	56.50%	0	1
PY1	DPH	UC Los Angeles Medical Center	Q-PC2	Comprehensive Diabetes Care: Eye Exam (CDC-E)	Reported	0	0	0	33	0	92	0	35.90%	0	1
PY1	DPH	UC Los Angeles Medical Center	Q-PC3	Comprehensive Diabetes Care: Blood Pressure Control (CDC-BP)	Reported	0	0	0	68	0	92	0	73.90%	0	1
PY1	DPH	UC Los Angeles Medical Center	Q-PC4	Asthma Medication Ratio (AMR)	Reported	0	0	0	12	0	None	4	None	4	1
PY1	DPH	UC Los Angeles Medical Center	Q-PC5	Medication Reconciliation Post Discharge (MRP)	Reported	0	0	0	69	0	99	0	69.70%	0	1
PY1	DPH	UC Los Angeles Medical Center	Q-PC6	7 Day Post-Discharge Follow-Up for High Risk Beneficiaries	Reported	0	0	0	None	1	None	4	None	1	1
PY1	DPH	UC Los Angeles Medical Center	Q-PC7	Children and Adolescent Access to PCP (CAP)	Reported	N/A	3	N/A	None	None	None	None	None	None	1
PY1	DPH	UC Los Angeles Medical Center	Q-PC7	? 12-24 Months	Reported	0	0	0	163	0	168	0	97.00%	0	1
PY1	DPH	UC Los Angeles Medical Center	Q-PC7	? 25 Months-6 Years	Reported	0	0	0	903	0	1068	0	84.60%	0	1
PY1	DPH	UC Los Angeles Medical Center	Q-PC7	? 7-11 Years	Reported	0	0	0	691	0	779	0	88.70%	0	1
PY1	DPH	UC Los Angeles Medical Center	Q-PC7	? 12-19 Years	Reported	0	0	0	932	0	1035	0	90.10%	0	1
PY1	DPH	UC Los Angeles Medical Center	Q-PC8	Childhood Immunization Status (CIS) Combination 3	Reported	0	0	0	100	0	149	0	67.10%	0	1
PY1	DPH	UC Los Angeles Medical Center	Q-PC9	Immunization for Adolescents (IMA) Combination 2	Reported	0	0	0	33	0	109	0	30.30%	0	1
PY1	DPH	UC Los Angeles Medical Center	Q-SC1	Atrial Fibrillation and Atrial Flutter: Chronic Anticoagulation Therapy	Reported	0	0	0	None	1	None	1	None	1	1
PY1	DPH	UC Los Angeles Medical Center	Q-SC2	Coronary Artery Disease (CAD): Antiplatelet Therapy	Reported	0	0	0	26	0	38	0	68.40%	0	1
PY1	DPH	UC Los Angeles Medical Center	Q-SC3	Coronary Artery Disease (CAD): Angiotensin-Converting Enzyme (ACE) Inhibitor or Angiotensin-Receptor Blocker (ARB) Therapy - Diabetes or Left Ventricular Systolic Dysfunction (LVEF < 40%)	Reported	0	0	0	13	0	None	4	None	4	1
PY1	DPH	UC Los Angeles Medical Center	Q-SC4	Coronary Artery Disease (CAD): Beta-Blocker Therapy-Prior Myocardial Infarction (MI) or Left Ventricular Systolic Dysfunction (LVEF <40%)	Reported	0	0	0	17	0	None	4	None	4	1
PY1	DPH	UC Los Angeles Medical Center	Q-SC5	Heart Failure (HF): Angiotensin-Converting Enzyme (ACE) Inhibitor or Angiotensin-Receptor Blocker (ARB) Therapy for Left Ventricular Systolic Dysfunction	Reported	0	0	0	None	1	None	4	None	1	1
PY1	DPH	UC Los Angeles Medical Center	Q-SC6	Heart Failure (HF): Beta-Blocker Therapy for Left Ventricular Systolic Dysfunction	Reported	0	0	0	None	1	None	4	None	1	1
PY1	DPH	UC Los Angeles Medical Center	Q-IP1	Surgical Site Infection (SSI) (Reported as SIR)	Reported	0	0	0	22	0	25.993	0	0.8464	0	1
PY1	DPH	UC Los Angeles Medical Center	Q-IP2	Perioperative Care: Selection of Prophylactic Antibiotic - 1st OR 2nd Generation Cephalosporin	Reported	0	0	0	607	0	752	0	80.70%	0	1
PY1	DPH	UC Los Angeles Medical Center	Q-IP3	Perioperative Care: Venous Thromboembolism (VTE) Prophylaxis	Reported	0	0	0	1118	0	1198	0	93.30%	0	1
PY1	DPH	UC Los Angeles Medical Center	Q-IP4	Prevention of Central Venous Catheter (CVC) - Related Bloodstream Infections	Reported	0	0	0	346	0	1507	0	23.00%	0	1
PY1	DPH	UC Los Angeles Medical Center	Q-IP5	Appropriate Treatment of Methicillin-Sensitive Staphylococcus Aureus (MSSA) Bacteremia	Reported	0	0	0	30	0	41	0	73.20%	0	1
PY1	DPH	UC Los Angeles Medical Center	Q-IP6	Stroke: Discharged on Antithrombotic Therapy (TJC STK-2)	Reported	0	0	0	60	0	60	0	100.00%	0	1
PY1	DPH	UC Los Angeles Medical Center	Q-RU1	Cardiac Stress Imaging Not Meeting Appropriate Use Criteria: Preoperative Evaluation in Low Risk Surgery Patients (QPP)	Reported	0	0	0	None	1	32	0	None	1	1
PY1	DPH	UC Los Angeles Medical Center	Q-RU2	Emergency Department Utilization of CT for Minor Blunt Head Trauma for Patients 18 Years and Older	Reported	0	0	0	268	0	292	0	91.80%	0	1
PY1	DPH	UC Los Angeles Medical Center	Q-RU3	Emergency Department Utilization of CT for Minor Blunt Head Trauma for Patients Aged 2 to 17 years old	Reported	0	0	0	0	0	46	0	0.00%	0	1
PY1	DPH	UC Los Angeles Medical Center	Q-RU4	Unplanned Reoperation within the 30 Day Postoperative Period (QPP)	No Data Entered	None	None	None	None	None	None	None	None	None	None
PY1	DPH	UC Los Angeles Medical Center	Q-RU5	Concurrent Use of Opioids and Benzodiazepines	Reported	N/A	3	N/A	N/A	3	N/A	3	N/A	3	1
PY1	DPH	UC Los Angeles Medical Center	Q-RU5	? RATE #1	Reported	0	0	0	None	1	31	0	None	1	1
PY1	DPH	UC Los Angeles Medical Center	Q-RU5	? RATE #2	Reported	0	0	0	None	1	62	0	None	1	1
PY1	DPH	UC San Diego Medical Center	Q-PC1	Comprehensive Diabetes Care: A1C Control (<8%) (CDC-H8)	Reported	0	0	0	265	0	384	0	69.00%	0	1
PY1	DPH	UC San Diego Medical Center	Q-PC2	Comprehensive Diabetes Care: Eye Exam (CDC-E)	Reported	0	0	0	221	0	384	0	57.60%	0	1
PY1	DPH	UC San Diego Medical Center	Q-PC3	Comprehensive Diabetes Care: Blood Pressure Control (CDC-BP)	Reported	0	0	0	268	0	384	0	69.80%	0	1
PY1	DPH	UC San Diego Medical Center	Q-PC4	Asthma Medication Ratio (AMR)	Reported	0	0	0	46	0	63	0	73.00%	0	1
PY1	DPH	UC San Diego Medical Center	Q-PC5	Medication Reconciliation Post Discharge (MRP)	Reported	0	0	0	205	0	333	0	61.60%	0	1
PY1	DPH	UC San Diego Medical Center	Q-PC6	7 Day Post-Discharge Follow-Up for High Risk Beneficiaries	Reported	0	0	0	20	0	44	0	45.50%	0	1
PY1	DPH	UC San Diego Medical Center	Q-PC7	Children and Adolescent Access to PCP (CAP)	Reported	N/A	3	N/A	None	None	None	None	None	None	1
PY1	DPH	UC San Diego Medical Center	Q-PC7	? 12-24 Months	Reported	0	0	0	0	0	0.001	0	0.00%	0	1
PY1	DPH	UC San Diego Medical Center	Q-PC7	? 25 Months-6 Years	Reported	0	0	0	12	0	None	4	None	4	1
PY1	DPH	UC San Diego Medical Center	Q-PC7	? 7-11 Years	Reported	0	0	0	None	1	None	1	None	1	1
PY1	DPH	UC San Diego Medical Center	Q-PC7	? 12-19 Years	Reported	0	0	0	None	1	None	1	None	1	1
PY1	DPH	UC San Diego Medical Center	Q-PC8	Childhood Immunization Status (CIS) Combination 3	Reported	0	0	0	0	0	0.001	0	0.00%	0	1
PY1	DPH	UC San Diego Medical Center	Q-PC9	Immunization for Adolescents (IMA) Combination 2	Reported	0	0	0	0	0	0.001	0	0.00%	0	1
PY1	DPH	UC San Diego Medical Center	Q-SC1	Atrial Fibrillation and Atrial Flutter: Chronic Anticoagulation Therapy	Reported	0	0	0	50	0	54	0	92.60%	0	1
PY1	DPH	UC San Diego Medical Center	Q-SC2	Coronary Artery Disease (CAD): Antiplatelet Therapy	Reported	0	0	0	196	0	233	0	84.10%	0	1
PY1	DPH	UC San Diego Medical Center	Q-SC3	Coronary Artery Disease (CAD): Angiotensin-Converting Enzyme (ACE) Inhibitor or Angiotensin-Receptor Blocker (ARB) Therapy - Diabetes or Left Ventricular Systolic Dysfunction (LVEF < 40%)	Reported	0	0	0	70	0	107	0	65.40%	0	1
PY1	DPH	UC San Diego Medical Center	Q-SC4	Coronary Artery Disease (CAD): Beta-Blocker Therapy-Prior Myocardial Infarction (MI) or Left Ventricular Systolic Dysfunction (LVEF <40%)	Reported	0	0	0	47	0	62	0	75.80%	0	1
PY1	DPH	UC San Diego Medical Center	Q-SC5	Heart Failure (HF): Angiotensin-Converting Enzyme (ACE) Inhibitor or Angiotensin-Receptor Blocker (ARB) Therapy for Left Ventricular Systolic Dysfunction	Reported	0	0	0	30	0	36	0	83.30%	0	1
PY1	DPH	UC San Diego Medical Center	Q-SC6	Heart Failure (HF): Beta-Blocker Therapy for Left Ventricular Systolic Dysfunction	Reported	0	0	0	34	0	36	0	94.40%	0	1
PY1	DPH	UC San Diego Medical Center	Q-IP1	Surgical Site Infection (SSI) (Reported as SIR)	Reported	0	0	0	55	0	37.797	0	1.4551	0	1
PY1	DPH	UC San Diego Medical Center	Q-IP2	Perioperative Care: Selection of Prophylactic Antibiotic - 1st OR 2nd Generation Cephalosporin	Reported	0	0	0	771	0	1247	0	61.80%	0	1
PY1	DPH	UC San Diego Medical Center	Q-IP3	Perioperative Care: Venous Thromboembolism (VTE) Prophylaxis	Reported	0	0	0	628	0	1022	0	61.50%	0	1
PY1	DPH	UC San Diego Medical Center	Q-IP4	Prevention of Central Venous Catheter (CVC) - Related Bloodstream Infections	Reported	0	0	0	630	0	1583	0	39.80%	0	1
PY1	DPH	UC San Diego Medical Center	Q-IP5	Appropriate Treatment of Methicillin-Sensitive Staphylococcus Aureus (MSSA) Bacteremia	Reported	0	0	0	16	0	None	4	None	4	1
PY1	DPH	UC San Diego Medical Center	Q-IP6	Stroke: Discharged on Antithrombotic Therapy (TJC STK-2)	Reported	0	0	0	51	0	52	0	98.10%	0	1
PY1	DPH	UC San Diego Medical Center	Q-RU1	Cardiac Stress Imaging Not Meeting Appropriate Use Criteria: Preoperative Evaluation in Low Risk Surgery Patients (QPP)	Reported	0	0	0	None	1	39	0	None	1	1
PY1	DPH	UC San Diego Medical Center	Q-RU2	Emergency Department Utilization of CT for Minor Blunt Head Trauma for Patients 18 Years and Older	Reported	0	0	0	0	0	0.001	0	0.00%	0	1
PY1	DPH	UC San Diego Medical Center	Q-RU3	Emergency Department Utilization of CT for Minor Blunt Head Trauma for Patients Aged 2 to 17 years old	Reported	0	0	0	0	0	0.001	0	0.00%	0	1
PY1	DPH	UC San Diego Medical Center	Q-RU4	Unplanned Reoperation within the 30 Day Postoperative Period (QPP)	No Data Entered	None	None	None	None	None	None	None	None	None	None
PY1	DPH	UC San Diego Medical Center	Q-RU5	Concurrent Use of Opioids and Benzodiazepines	Reported	N/A	3	N/A	N/A	3	N/A	3	N/A	3	1
PY1	DPH	UC San Diego Medical Center	Q-RU5	? RATE #1	Reported	0	0	0	22	0	None	4	None	4	1
PY1	DPH	UC San Diego Medical Center	Q-RU5	? RATE #2	Reported	0	0	0	27	0	37	0	73.00%	0	1
PY1	DPH	UC San Francisco Medical Center	Q-PC1	Comprehensive Diabetes Care: A1C Control (<8%) (CDC-H8)	Reported	0	0	0	387	0	708	0	54.70%	0	1
PY1	DPH	UC San Francisco Medical Center	Q-PC2	Comprehensive Diabetes Care: Eye Exam (CDC-E)	Reported	0	0	0	465	0	708	0	65.70%	0	1
PY1	DPH	UC San Francisco Medical Center	Q-PC3	Comprehensive Diabetes Care: Blood Pressure Control (CDC-BP)	Reported	0	0	0	468	0	708	0	66.10%	0	1
PY1	DPH	UC San Francisco Medical Center	Q-PC4	Asthma Medication Ratio (AMR)	Reported	0	0	0	95	0	182	0	52.20%	0	1
PY1	DPH	UC San Francisco Medical Center	Q-PC5	Medication Reconciliation Post Discharge (MRP)	Reported	0	0	0	263	0	540	0	48.70%	0	1
PY1	DPH	UC San Francisco Medical Center	Q-PC6	7 Day Post-Discharge Follow-Up for High Risk Beneficiaries	Reported	0	0	0	62	0	103	0	60.20%	0	1
PY1	DPH	UC San Francisco Medical Center	Q-PC7	Children and Adolescent Access to PCP (CAP)	Reported	N/A	3	N/A	None	None	None	None	None	None	1
PY1	DPH	UC San Francisco Medical Center	Q-PC7	? 12-24 Months	Reported	0	0	0	135	0	147	0	91.80%	0	1
PY1	DPH	UC San Francisco Medical Center	Q-PC7	? 25 Months-6 Years	Reported	0	0	0	1148	0	1427	0	80.50%	0	1
PY1	DPH	UC San Francisco Medical Center	Q-PC7	? 7-11 Years	Reported	0	0	0	858	0	990	0	86.70%	0	1
PY1	DPH	UC San Francisco Medical Center	Q-PC7	? 12-19 Years	Reported	0	0	0	1071	0	1211	0	88.40%	0	1
PY1	DPH	UC San Francisco Medical Center	Q-PC8	Childhood Immunization Status (CIS) Combination 3	Reported	0	0	0	186	0	231	0	80.50%	0	1
PY1	DPH	UC San Francisco Medical Center	Q-PC9	Immunization for Adolescents (IMA) Combination 2	Reported	0	0	0	63	0	136	0	46.30%	0	1
PY1	DPH	UC San Francisco Medical Center	Q-SC1	Atrial Fibrillation and Atrial Flutter: Chronic Anticoagulation Therapy	Reported	0	0	0	27	0	31	0	87.10%	0	1
PY1	DPH	UC San Francisco Medical Center	Q-SC2	Coronary Artery Disease (CAD): Antiplatelet Therapy	Reported	0	0	0	114	0	127	0	89.80%	0	1
PY1	DPH	UC San Francisco Medical Center	Q-SC3	Coronary Artery Disease (CAD): Angiotensin-Converting Enzyme (ACE) Inhibitor or Angiotensin-Receptor Blocker (ARB) Therapy - Diabetes or Left Ventricular Systolic Dysfunction (LVEF < 40%)	Reported	0	0	0	43	0	61	0	70.50%	0	1
PY1	DPH	UC San Francisco Medical Center	Q-SC4	Coronary Artery Disease (CAD): Beta-Blocker Therapy-Prior Myocardial Infarction (MI) or Left Ventricular Systolic Dysfunction (LVEF <40%)	Reported	0	0	0	33	0	42	0	78.60%	0	1
PY1	DPH	UC San Francisco Medical Center	Q-SC5	Heart Failure (HF): Angiotensin-Converting Enzyme (ACE) Inhibitor or Angiotensin-Receptor Blocker (ARB) Therapy for Left Ventricular Systolic Dysfunction	Reported	0	0	0	33	0	40	0	82.50%	0	1
PY1	DPH	UC San Francisco Medical Center	Q-SC6	Heart Failure (HF): Beta-Blocker Therapy for Left Ventricular Systolic Dysfunction	Reported	0	0	0	27	0	40	0	67.50%	0	1
PY1	DPH	UC San Francisco Medical Center	Q-IP1	Surgical Site Infection (SSI) (Reported as SIR)	Reported	0	0	0	47	0	53.335	0	0.8812	0	1
PY1	DPH	UC San Francisco Medical Center	Q-IP2	Perioperative Care: Selection of Prophylactic Antibiotic - 1st OR 2nd Generation Cephalosporin	Reported	0	0	0	6049	0	9320	0	64.90%	0	1
PY1	DPH	UC San Francisco Medical Center	Q-IP3	Perioperative Care: Venous Thromboembolism (VTE) Prophylaxis	Reported	0	0	0	3543	0	3906	0	90.70%	0	1
PY1	DPH	UC San Francisco Medical Center	Q-IP4	Prevention of Central Venous Catheter (CVC) - Related Bloodstream Infections	Reported	0	0	0	27	0	1698	0	1.60%	0	1
PY1	DPH	UC San Francisco Medical Center	Q-IP5	Appropriate Treatment of Methicillin-Sensitive Staphylococcus Aureus (MSSA) Bacteremia	Reported	0	0	0	32	0	62	0	51.60%	0	1
PY1	DPH	UC San Francisco Medical Center	Q-IP6	Stroke: Discharged on Antithrombotic Therapy (TJC STK-2)	Reported	0	0	0	48	0	57	0	84.20%	0	1
PY1	DPH	UC San Francisco Medical Center	Q-RU1	Cardiac Stress Imaging Not Meeting Appropriate Use Criteria: Preoperative Evaluation in Low Risk Surgery Patients (QPP)	Reported	0	0	0	18	0	215	0	8.40%	0	1
PY1	DPH	UC San Francisco Medical Center	Q-RU2	Emergency Department Utilization of CT for Minor Blunt Head Trauma for Patients 18 Years and Older	Reported	0	0	0	76	0	177	0	42.90%	0	1
PY1	DPH	UC San Francisco Medical Center	Q-RU3	Emergency Department Utilization of CT for Minor Blunt Head Trauma for Patients Aged 2 to 17 years old	Reported	0	0	0	None	1	None	4	None	1	1
PY1	DPH	UC San Francisco Medical Center	Q-RU4	Unplanned Reoperation within the 30 Day Postoperative Period (QPP)	Reported	0	0	0	19	0	686	0	2.80%	0	1
PY1	DPH	UC San Francisco Medical Center	Q-RU5	Concurrent Use of Opioids and Benzodiazepines	Reported	N/A	3	N/A	N/A	3	N/A	3	N/A	3	1
PY1	DPH	UC San Francisco Medical Center	Q-RU5	? RATE #1	Reported	0	0	0	82	0	556	0	14.80%	0	1
PY1	DPH	UC San Francisco Medical Center	Q-RU5	? RATE #2	Reported	0	0	0	110	0	805	0	13.70%	0	1
PY1	DPH	Ventura County Medical Center	Q-PC1	Comprehensive Diabetes Care: A1C Control (<8%) (CDC-H8)	Reported	0	0	0	1632	0	2729	0	59.80%	0	1
PY1	DPH	Ventura County Medical Center	Q-PC2	Comprehensive Diabetes Care: Eye Exam (CDC-E)	Reported	0	0	0	1164	0	2729	0	42.70%	0	1
PY1	DPH	Ventura County Medical Center	Q-PC3	Comprehensive Diabetes Care: Blood Pressure Control (CDC-BP)	Reported	0	0	0	2024	0	2729	0	74.20%	0	1
PY1	DPH	Ventura County Medical Center	Q-PC4	Asthma Medication Ratio (AMR)	Reported	0	0	0	681	0	1355	0	50.30%	0	1
PY1	DPH	Ventura County Medical Center	Q-PC5	Medication Reconciliation Post Discharge (MRP)	Not Reported	None	None	None	None	None	None	None	None	None	None
PY1	DPH	Ventura County Medical Center	Q-PC6	7 Day Post-Discharge Follow-Up for High Risk Beneficiaries	Reported	0	0	0	226	0	479	0	47.20%	0	1
PY1	DPH	Ventura County Medical Center	Q-PC7	Children and Adolescent Access to PCP (CAP)	Reported	N/A	3	N/A	None	None	None	None	None	None	1
PY1	DPH	Ventura County Medical Center	Q-PC7	? 12-24 Months	Reported	0	0	0	1718	0	1831	0	93.80%	0	1
PY1	DPH	Ventura County Medical Center	Q-PC7	? 25 Months-6 Years	Reported	0	0	0	6174	0	7310	0	84.50%	0	1
PY1	DPH	Ventura County Medical Center	Q-PC7	? 7-11 Years	Reported	0	0	0	6345	0	7726	0	82.10%	0	1
PY1	DPH	Ventura County Medical Center	Q-PC7	? 12-19 Years	Reported	0	0	0	7293	0	9285	0	78.60%	0	1
PY1	DPH	Ventura County Medical Center	Q-PC8	Childhood Immunization Status (CIS) Combination 3	Reported	0	0	0	1189	0	1488	0	79.90%	0	1
PY1	DPH	Ventura County Medical Center	Q-PC9	Immunization for Adolescents (IMA) Combination 2	Reported	0	0	0	319	0	943	0	33.80%	0	1
PY1	DPH	Ventura County Medical Center	Q-SC1	Atrial Fibrillation and Atrial Flutter: Chronic Anticoagulation Therapy	Reported	0	0	0	87	0	119	0	73.10%	0	1
PY1	DPH	Ventura County Medical Center	Q-SC2	Coronary Artery Disease (CAD): Antiplatelet Therapy	Reported	0	0	0	415	0	486	0	85.40%	0	1
PY1	DPH	Ventura County Medical Center	Q-SC3	Coronary Artery Disease (CAD): Angiotensin-Converting Enzyme (ACE) Inhibitor or Angiotensin-Receptor Blocker (ARB) Therapy - Diabetes or Left Ventricular Systolic Dysfunction (LVEF < 40%)	Reported	0	0	0	200	0	246	0	81.30%	0	1
PY1	DPH	Ventura County Medical Center	Q-SC4	Coronary Artery Disease (CAD): Beta-Blocker Therapy-Prior Myocardial Infarction (MI) or Left Ventricular Systolic Dysfunction (LVEF <40%)	Reported	0	0	0	58	0	67	0	86.60%	0	1
PY1	DPH	Ventura County Medical Center	Q-SC5	Heart Failure (HF): Angiotensin-Converting Enzyme (ACE) Inhibitor or Angiotensin-Receptor Blocker (ARB) Therapy for Left Ventricular Systolic Dysfunction	Reported	0	0	0	66	0	74	0	89.20%	0	1
PY1	DPH	Ventura County Medical Center	Q-SC6	Heart Failure (HF): Beta-Blocker Therapy for Left Ventricular Systolic Dysfunction	Reported	0	0	0	67	0	73	0	91.80%	0	1
PY1	DPH	Ventura County Medical Center	Q-IP1	Surgical Site Infection (SSI) (Reported as SIR)	Reported	0	0	0	None	1	6.399	0	None	1	1
PY1	DPH	Ventura County Medical Center	Q-IP2	Perioperative Care: Selection of Prophylactic Antibiotic - 1st OR 2nd Generation Cephalosporin	Reported	0	0	0	777	0	947	0	82.10%	0	1
PY1	DPH	Ventura County Medical Center	Q-IP3	Perioperative Care: Venous Thromboembolism (VTE) Prophylaxis	Reported	0	0	0	1004	0	1054	0	95.30%	0	1
PY1	DPH	Ventura County Medical Center	Q-IP4	Prevention of Central Venous Catheter (CVC) - Related Bloodstream Infections	Reported	0	0	0	0	0	310	0	0.00%	0	1
PY1	DPH	Ventura County Medical Center	Q-IP5	Appropriate Treatment of Methicillin-Sensitive Staphylococcus Aureus (MSSA) Bacteremia	Not Reported	None	None	None	None	None	None	None	None	None	None
PY1	DPH	Ventura County Medical Center	Q-IP6	Stroke: Discharged on Antithrombotic Therapy (TJC STK-2)	Not Reported	None	None	None	None	None	None	None	None	None	None
PY1	DPH	Ventura County Medical Center	Q-RU1	Cardiac Stress Imaging Not Meeting Appropriate Use Criteria: Preoperative Evaluation in Low Risk Surgery Patients (QPP)	Reported	0	0	0	None	1	175	0	None	1	1
PY1	DPH	Ventura County Medical Center	Q-RU2	Emergency Department Utilization of CT for Minor Blunt Head Trauma for Patients 18 Years and Older	Reported	0	0	0	82	0	133	0	61.70%	0	1
PY1	DPH	Ventura County Medical Center	Q-RU3	Emergency Department Utilization of CT for Minor Blunt Head Trauma for Patients Aged 2 to 17 years old	Not Reported	None	None	None	None	None	None	None	None	None	None
PY1	DPH	Ventura County Medical Center	Q-RU4	Unplanned Reoperation within the 30 Day Postoperative Period (QPP)	No Data Entered	None	None	None	None	None	None	None	None	None	None
PY1	DPH	Ventura County Medical Center	Q-RU5	Concurrent Use of Opioids and Benzodiazepines	Not Reported	None	None	None	None	None	None	None	None	None	None